Uniprot,Genes,Usual name,protein name,Sequence change,Alteration,N base(s),Base substituted,Classification,Status,Using In silico prediction?,Fonctional test,Functional approach?,Consequence,N controls,Techniques used,Change/define RFLP,Disease related symptoms,Associated phenotype,Ancestry/origin,Comment,Input date,References,Location,Predictions,Prediction(0-1)
O15553_Leu28Val,MEFV,L28V,p.(Leu28Val),c.82C>G,substitution,1,C>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,Bassin Méditerranéen/Poland/France/Armenian/Greece,--,2019-05-13,Hot A  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 1,0.928,1
O15553_Val67Glu,MEFV,V67E,p.(Val67Glu),c.200T>A,substitution,1,T>A,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Non symptomatic ,NO,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 1,0.784,1
O15553_Gln97Lys,MEFV,Q97K,p.(Gln97Lys),c.289C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,350,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,United states/,--,2011-01-04,Aksentijevich I   Personal communication,Exon 2,0.701,1
O15553_Gln97Arg,MEFV,Q97R,p.(Gln97Arg),c.290A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,600,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-03-07,Kurtulgan HK  Bagci G   Personal communication,Exon 2,0.772,1
O15553_Ala105Glu,MEFV,A105E,p.(Ala105Glu),c.314C>A ,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-06-28,Serdar Oztuzcu  Mustafa Ulasli  Yusuf Ziya Igci  Sercan Ergun  Ahmet Arslan   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/24469716,Exon 2,0.702,1
O15553_Ser108Arg,MEFV,S108R,p.(Ser108Arg),c.322A>C,substitution,1,A>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,RFLP Sequencing Sanger ,creates AciI ccgc,Symptomatic ,UNKNOWN,Lebanon/,--,2002-02-12,Medlej-Hashim M  Saab O  Salem N  Chouery E  Delague V  Mégarbané A   Personal communication,Exon 2,0.873,1
O15553_Ser108Gly,MEFV,S108G,p.(Ser108Gly),c.322A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,>999,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,Tunisia/Arab,--,2017-08-18,M.E. van Gijn   Personal communication,Exon 2,0.671,1
O15553_Leu110Pro,MEFV,L110P,p.(Leu110Pro),c.329T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,RFLP Sequencing Sanger ,creates AvaI c/ycgrg,Symptomatic ,UNKNOWN,Spain/,--,2001-12-11,Domingo C  et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10854105,Exon 2,0.966,1
O15553_Gly111Arg,MEFV,G111R,p.(Gly111Arg),c.331G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,577,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Crohn's disease ,Belgium/Caucasian,--,2012-10-01,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.69,1
O15553_Gly111Glu,MEFV,G111E,p.(Gly111Glu),c.332G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,600,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,/,--,2011-09-05,Salem N  Chouery E  Corbani S  Mégarbané A   Personal communication,Exon 2,0.979,1
O15553_Pro115Arg,MEFV,P115R,p.(Pro115Arg),c.344C>G,substitution,1,C>G,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Symptomatic Non symptomatic ,Undefined-AID ,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 2,0.627,1
O15553_His123Gln,MEFV,H123Q,p.(His123Gln),c.369C>A,substitution,1,C>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2014-11-27,Coskun  Salih  Ece  Aydin  Cim  Abdullah  Uluca  Unal   Personal communication,Exon 2,0.802,1
O15553_Gly136Arg,MEFV,G136R,p.(Gly136Arg),c.406G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,/,This patient was found to be V377I homozygous (MVK gene),2007-08-22,Gabriele Wildhardt   Personal communication,Exon 2,0.719,1
O15553_Gly136Trp,MEFV,G136W,p.(Gly136Trp),c.406G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,577,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Crohn's disease ,Belgium/Caucasian,--,2012-10-01,Villani AC et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.806,1
O15553_Gly136Glu,MEFV,G136E,p.(Gly136Glu),c.407G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,United kingdom/England/Italy,--,2019-11-08,Touitou I   Personal communication,Exon 2,0.854,1
O15553_Glu148Gln,MEFV,E148Q,p.(Glu148Gln),c.442G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,3100,DGGE RFLP Sequencing Sanger ,destroys AvaI c/ycgrg,Symptomatic ,FMF atypical PAAD-FMF (with criteria) Indeterminate colitis Recurrent Arthritis Recurrent Fever Rheumatoid Arthritis ,France/Jewish Non Ashkenasi,E148Q is possibly a functionnal polymorphism,2001-12-11,Bernot et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/9668175,Exon 2,0.748,1
O15553_Glu148Val,MEFV,E148V,p.(Glu148Val),c.443A>T,substitution,1,A>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,DGGE RFLP Sequencing Sanger ,destroys AvaI c/ycgrg,Symptomatic ,UNKNOWN,Turkey/,--,2001-12-11,"Tunca et al   Congress abstract:II International Familial Mediterranean Conference, Antalya, Turkey, May 2000",Exon 2,0.61,1
O15553_Glu148Asp,MEFV,E148D,p.(Glu148Asp),c.444G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,Turkey/Caucasian,--,2015-03-26,Berdeli A   Mir S  Atan M Tigli D.   Personal communication,Exon 2,0.627,1
O15553_Arg151Ser,MEFV,R151S,p.(Arg151Ser),c.453G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Kurdish,--,2008-01-14,Berdeli A Tigli D Ozdemir N   Personal communication,Exon 2,0.36,0
O15553_Gly152Arg,MEFV,G152R,p.(Gly152Arg),c.454G>C,substitution,1,G>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,PAAD-FMF (with criteria) ,/,--,--,--,Exon 2,0.933,1
O15553_Ser154Pro,MEFV,S154P,p.(Ser154Pro),c.460T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-02-28,Berdeli A  Tigili D Atan M Demirel I   Personal communication,Exon 2,0.931,1
O15553_Arg155Thr,MEFV,R155T,p.(Arg155Thr),c.464G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2014-04-30,Serdar Oztuzcu  Mustafa Ulasli  Yusuf Ziya Igci  Sercan Ergun  Ahmet Arslan   Personal communication,Exon 2,0.895,1
O15553_Glu163Ala,MEFV,E163A,p.(Glu163Ala),c.488A>C,substitution,1,A>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,NO,Symptomatic ,UNKNOWN,Spain/,Incomplete penetrance,2002-06-18,Aldea A  Arostegui JI  Campistol JM  Yagüe J   Personal communication,Exon 2,0.879,1
O15553_Ala165Thr,MEFV,A165T,p.(Ala165Thr),c.493G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,370,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Scotland/Caucasian,--,2012-10-02,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.708,1
O15553_Ser166Leu,MEFV,S166L,p.(Ser166Leu),c.497C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,NO,Symptomatic ,Recurrent Fever ,Turkey/Caucasian,--,2010-10-13,Berdeli A  Tigili D  Pasolar A  Atan M  Nalbantoglu S.   Personal communication,Exon 2,0.715,1
O15553_Gln172Pro,MEFV,Q172P,p.(Gln172Pro),c.515A>C,substitution,1,A>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,336,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Jordan/Arab,--,2009-06-04,Kohilan A  El-Shanti H   Personal communication,Exon 2,0.979,1
O15553_Pro175His,MEFV,P175H,p.(Pro175His),c.524C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Spain/,--,2004-11-10,Arostegui JI  Garcia-Consuegra J  Franco W  Yague J   Personal communication,Exon 2,0.897,1
O15553_Ser179Ile,MEFV,S179I,p.(Ser179Ile),c.536G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,50,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/,--,2004-09-01,Timmann C  et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/14636645,Exon 2,0.93,1
O15553_Pro180Arg,MEFV,P180R,p.(Pro180Arg),c.539C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,Spain/,--,2005-08-16,Arostegui JI  Martinez M  Garcia-Consuegra J  Yague J   Personal communication,Exon 2,0.801,1
O15553_Pro183Thr,MEFV,P183T,p.(Pro183Thr),c.547C>A,substitution,1,C>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Behçet's disease ,China/Asian,--,2021-01-26,Borroco C  Kone-Paut I  Rittore C  Sarrabay G  Boursier G  Touitou I   Personal communication,Exon 2,0.926,1
O15553_Gly196Trp,MEFV,G196W,p.(Gly196Trp),c.586G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,1000,RFLP Sequencing Sanger ,destroys MnlI cctc,Symptomatic ,FMF atypical ,Niger/,--,2007-06-12,Taillefer L  Dumont B  Touitou  I   Personal communication,Exon 2,0.931,1
O15553_Gly196Arg,MEFV,G196R,p.(Gly196Arg),c.586G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,40,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Italy/Caucasian,"fever, oral aphtosis, arthalgia, limphadenopathy ",2013-09-10,lucherini OM  Vitale A  Magnotti F  Guerrini S  Caso F  Brizi G  Galeazzi M  Cantarini L     Personal communication,Exon 2,0.878,1
O15553_Gly197Arg,MEFV,G197R,p.(Gly197Arg),c.589G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,"MKD-mild (HIDS) A 14 year old Turkish female complains about attacks of abdominal pain and fever lasting 4 to 7 days accompanyig with chest pain and arthralgias of the knees since age of 11. Attacks repeat 2-3 times a year. In most of her attacks, she had erythematous skin rash all over her body.In some of her attacks she had epistaxis as well. She did not respond colchine well. She has no family history of autoinflammatory disease, however his father's aunt died of renal failure. Sequence analysis of her MVK gene revealed homozygous c.769-38C>T mutation. A novel heterozygous mutation has been found in exon 2 of the MEFV gene such as: G197RG>C as well.",Turkey/Caucasian,--,2011-12-13,Erken E  Dinkci S  Eroglu A   Personal communication,Exon 2,0.817,1
O15553_Leu203Pro,MEFV,L203P,p.(Leu203Pro),c.608T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,347,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,Canada/Caucasian,--,2012-10-01,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.968,1
O15553_Asn206Ser,MEFV,N206S,p.(Asn206Ser),c.617A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,577,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Belgium/Caucasian,--,2012-10-02,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.161,0
O15553_Asn206Lys,MEFV,N206K ,p.(Asn206Lys),c.618C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,2,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,complex genotype with M694V R202Q N206K,2013-04-18,Metin Kilinc  Eda Ganiyusufoglu  Sefa Cifci  Seref Olgar  Elif Sahin   Ahmet Kose.   Congress abstract:Turkish Clinical Bichemistry National Congress Izmir/Turkey April 2013,Exon 2,0.69,1
O15553_Ser208Cys,MEFV,S208C,p.(Ser208Cys),c.622A>T,substitution,1,A>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever ,Pakistan/Asian,--,2012-07-03,Rowczenio DM  Lachmann HJ  Hawkins PN    Personal communication,Exon 2,0.749,1
O15553_Gly218Ala,MEFV,G218A,p.(Gly218Ala),c.653G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,239,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,Belgium/Caucasian,--,2012-10-02,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.907,1
O15553_Gly222Arg,MEFV,G222R,p.(Gly222Arg),c.664G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,577,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Ulcerative Colitis ,Belgium/Caucasian,--,2012-10-02,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 2,0.876,1
O15553_Glu225Gly,MEFV,E225G,p.(Glu225Gly),c.674A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever ,Italy/Caucasian,--,2011-09-01,Ferretti M et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19877056,Exon 2,0.851,1
O15553_Glu230Lys,MEFV,E230K,p.(Glu230Lys),c.688G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Armenia/,--,2001-12-11,"Torozyan Y  et al   Congress abstract:50th annual meeting of the American Society of Human Genetics, Philadelphia, USA, October 2000",Exon 2,0.87,1
O15553_Met238Ile,MEFV,M238I,p.(Met238Ile),c.714G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,creates TaqI t/cga,Symptomatic ,Recurrent Fever ,Italy and Tunisia/,--,2014-10-07,Galozzi P  Greco E  Moz S  Martini G  Basso D  Sfriso P  Zulian F  Plebani M  Punzi L   Personal communication,Exon 2,0.681,1
O15553_Thr249Ala,MEFV,T249A,p.(Thr249Ala),c.745A>G,substitution,1,A>G,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Symptomatic Non symptomatic ,Undefined-AID ,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 2,0.4,0
O15553_Gly250Ala,MEFV,G250A,p.(Gly250Ala),c.749G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/,"hemophagocytic lymphohistiocytosis, urticaria",2020-05-20,Belot A  Rittore C  Boursier G  Touitou I   Personal communication,Exon 3,0.997,1
O15553_Glu251Lys,MEFV,E251K,p.(Glu251Lys),c.751G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,324,Sequencing Sanger ,creates MboII gaaga,Symptomatic ,UNKNOWN,Germany/,--,2002-12-20,Lohse P   Personal communication,Exon 2,0.953,1
O15553_Pro257Leu,MEFV,P257L,p.(Pro257Leu),c.770C>T,substitution,1,C>T,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Non symptomatic ,NO,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 2,0.852,1
O15553_Pro283Arg,MEFV,P283R,p.(Pro283Arg),c.848C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,644,Sequencing Sanger ,destroys AccIII t/ccgga,Symptomatic ,UNKNOWN,Turkey/,"This mutation was found together with E148Q  As regards FMF newly diagnosed 40 years old male patient  of turkish origin, experiences febrile attacks since 12-15 years (up to 41°C) up to 6 times a year, accompanied by a feeling of heavy illness, pain in joints, headache, skin lesions in the face near the eyes.  has 4 unaffected children aged 12-20, his parents and grandparents apparently unaffected, too.  ",2003-12-09,Haverkamp  T   Personal communication,Exon 2,0.929,1
O15553_Pro283Leu,MEFV,P283L,p.(Pro283Leu),c.848C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,60,Sequencing Sanger ,destroys HpaII c/cgg,Symptomatic ,Recurrent Fever ,France/Maghrebian,--,2005-05-23,Danner  Dumont B Touitou I   Personal communication,Exon 2,0.885,1
O15553_Ser288Tyr,MEFV,S288Y,p.(Ser288Tyr),c.863C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-06-29,Serdar Oztuzcu  Mustafa Ulasli  Yusuf Ziya Igci  Sercan Ergun  Ahmet Arslan   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/24469716,Exon 2,0.665,1
O15553_Ala289Val,MEFV,A289V,p.(Ala289Val),c.866C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,210,RFLP Sequencing Sanger ,creates AciI ccgc,Symptomatic ,PAAD-FMF (with criteria) ,Lebanon/,--,2005-06-07,Corbani  S  Salem  N  Jalkh  N  Chouery  E  Mégarbané  A   Personal communication,Exon 2,0.839,1
O15553_Ala289Glu,MEFV,A289E,p.(Ala289Glu),c.866C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-06-28,Serdar Oztuzcu  Mustafa Ulasli  Yusuf Ziya Igci  Sercan Ergun  Ahmet Arslan  Muammer Ozgur Cevik   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/24469716,Exon 2,0.968,1
O15553_Thr309Met,MEFV,T309M,p.(Thr309Met),c.926C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,428,RFLP Sequencing Sanger ,creates NlaIII catg/,Symptomatic ,PAAD-FMF (with criteria) ,Lebanon/,--,2006-01-18,Salem N  Corbani S  Chouery E  Jalkh N  Medlej-Hashim M  Megarbane A   Personal communication,Exon 3,0.83,1
O15553_Arg314Cys,MEFV,R314C,p.(Arg314Cys),c.940C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Lebanon/sunnite Lebanese,--,2011-04-14,Megarbane M  Chouery E  Salem N  Corbani S   Personal communication,Exon 3,0.797,1
O15553_Val338Leu,MEFV,V338L,p.(Val338Leu),c.1012G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2014-02-20,Serdar Oztuzcu  Mustafa Ulasli  Yusuf Ziya Igci  Sercan Ergun  Ahmet Arslan   Personal communication,Exon 3,0.87,1
O15553_Pro350Ser,MEFV,P350S,p.(Pro350Ser),c.1048C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,Unclassified autoinflammatory syndrome ,Netherlands/Caucasian,--,2015-01-06,M.E. Van Gijn   Personal communication,Exon 3,0.921,1
O15553_Pro350Arg,MEFV,P350R,p.(Pro350Arg),c.1049C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2010-03-18,Berdeli A  Tigili D  Pasolar A  Atan M  Nalbantoglu S.   Personal communication,Exon 3,0.925,1
O15553_Arg361Thr,MEFV,R361T,p.(Arg361Thr),c.1082G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2014-11-18,Salih Coskun   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/25703702,Exon 3,0.791,1
O15553_Ser363Asn,MEFV,S363N,p.(Ser363Asn),c.1088G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,400,Sequencing Sanger ,UNKNOWN,Symptomatic ,Early Arthritis Early-onset polyarthritis,Mauritania/African,--,2014-02-25,Anton J  Ruiz-Ortiz E  Gonzalez-Roca  E  Yague J  Arostegui  Juan I   Personal communication,Exon 3,0.912,1
O15553_Pro364Leu,MEFV,P364L,p.(Pro364Leu),c.1091C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,400,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,/,--,2009-10-19,CORBANI S  SALEM N  CHOUERY E  MEGARBANE  A   Personal communication,Exon 3,0.949,1
O15553_Pro369Ser,MEFV,P369S,p.(Pro369Ser),c.1105C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,850,RFLP Sequencing Sanger ,creates AluI ag/ct,Symptomatic ,UNKNOWN,France/Jewish Ashkenasi,Almost always identified with R408Q in cis.,2001-12-11,Aksentijevich et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10090880,Exon 3,0.765,1
O15553_Pro373Leu,MEFV,P373L,p.(Pro373Leu),c.1118C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,40,Sequencing Sanger ,UNKNOWN,Symptomatic ,"recurrent fever, arthritis",Italy/Caucasian,"Also caused dominant classical FMF in a large British family (D Rowczenio, personal communication)",2013-09-10,lucherini OM  Vitale A  Magnotti F  Guerrini S  Caso F  Brizi G  Galeazzi M  Cantarini L     Personal communication,Exon 3,0.924,1
O15553_Gln383Lys,MEFV,Q383K,p.(Gln383Lys),c.1147C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,400,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Lebanon/ARMENIAN,--,2008-01-21,Corbani S Salem N Chouery E Megarbane A   Personal communication,Exon 3,0.808,1
O15553_Arg408Gln,MEFV,R408Q,p.(Arg408Gln),c.1223G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,850,RFLP Sequencing Sanger ,destroys HpaII c/cgg,Unknown,UNKNOWN,Armenia/,Always identified with P369S in cis. ,2001-12-11,Cazeneuve C  et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10364520,Exon 3,0.884,1
O15553_Ile423Val,MEFV,I423V,p.(Ile423Val),c.1267A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,1498,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,/Caucasian,"found heterozygote without 2nd mutation  I423 conserved among mammals (homo, pan, canis, rattus, mus)",2005-12-29,Haverkamp  T  Paralyova  L   Personal communication,Exon 4,0.955,1
O15553_Gln426Arg,MEFV,Q426R,p.(Gln426Arg),c.1277A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever ,France/Caucasian,--,2012-12-07,Sanchez A Dumont B Philibert L Touitou I   Personal communication,Exon 4,0.91,1
O15553_Ser442Thr,MEFV,S442T,p.(Ser442Thr),c.1324T>A,substitution,1,T>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,/Mediterranean,--,2019-05-13,Meinzer  U  Rittore  C  Ruault  V  Boursier  G  Touitou  I   Personal communication,Exon 4,0.928,1
O15553_Glu474Lys,MEFV,E474K,p.(Glu474Lys),c.1420G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,RFLP Sequencing Sanger SSCP ,destroys MvaI cc/wgg,Symptomatic ,UNKNOWN,Lebanon/,--,2002-02-15,Medlej-Hashim  M  Corbani S  Chouery E  Salem N  Delague V  Mégarbané A   Personal communication,Exon 5,0.89,1
O15553_His478Tyr,MEFV,H478Y,p.(His478Tyr),c.1432C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,destroys MwoI gcnnnnn/nngc,Symptomatic ,PAAD-FMF (with criteria) Amyloidosis,Spain/,Dominant inheritance,2002-06-18,Aldea A  Arostegui JI  Campistol JM  Yagüe J   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/14679589,Exon 5,0.666,1
O15553_Val487Met,MEFV,V487M,p.(Val487Met),c.1459G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,50,Sequencing Sanger ,NO,Symptomatic ,UNKNOWN,Italian+French/Caucasian,--,2002-01-17,Baffico M  Baldi M    Personal communication,Exon 5,0.386,0
O15553_Arg495Lys,MEFV,R495K,p.(Arg495Lys),c.1484G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,PAAD-FMF (with criteria) ,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 5,0.924,1
O15553_Arg501Gly,MEFV,R501G,p.(Arg501Gly),c.1501C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,50,Sequencing Sanger ,creates Bse118I r/ccggy,Symptomatic ,UNKNOWN,Italy/,--,2002-01-17,Baffico M  Baldi  M   Personal communication,Exon 5,0.929,1
O15553_Asp505Gly,MEFV,D505G,p.(Asp505Gly),c.1514A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,/,--,2013-05-06,Van Gijn M   Personal communication,Exon 5,0.915,1
O15553_Leu508Gln,MEFV,L508Q,p.(Leu508Gln),c.1523T>A,substitution,1,T>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,PAAD-FMF (with criteria) ,/,--,--,--,Exon 5,0.514,1
O15553_Asp510Asn,MEFV,D510N,p.(Asp510Asn),c.1528G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,In silico analysis controversial;Tested on polyphen 2 and pmut : probably damaging;Tested on sift and provean: tolerated  ,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever ,Greece/,"2 years old boy presenting from the age of 15 months old reccurent (weekly) episodes of fever (up to 41 degrees celsius. He also displayed supraventricular tachycardia at birth, which disappeared later.  The patient presents on the other chromosome the p.e148q/c.442g>c substitution.  ",2014-10-21,ALFALAB  GREECE   Personal communication,Exon 5,0.898,1
O15553_Ala511Val,MEFV,A511V,p.(Ala511Val),c.1532C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,RFLP Sequencing Sanger ,destroys HhaI gcg/c,Symptomatic ,PAAD-FMF (with criteria) ,Chile/,--,2010-07-06,Akar N  Ozturk A  Arslan C  Akar E  Taucher  SC  Passalacqua C.   Personal communication,Exon 5,0.821,1
O15553_Ala511Glu,MEFV,A511E,p.(Ala511Glu),c.1532C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Lebanon/,--,2015-08-11,Salem N  Corbani S  Ghosn R  Chouery E  Megarbane A   Personal communication,Exon 5,0.617,1
O15553_Gly514Glu,MEFV,G514E,p.(Gly514Glu),c.1541G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,200,DGGE Sequencing Sanger ,creates MnlI cctc,Symptomatic ,FMF atypical ,France/,--,2006-10-17,Kone-Paut  I  Dumont  B  Touitou  I   Personal communication,Exon 5,0.927,1
O15553_Lys539Asn,MEFV,K539N,p.(Lys539Asn),c.1617G>T,substitution,1,G>T,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Non symptomatic ,NO,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 7,0.842,1
O15553_Pro550Ala,MEFV,P550A,p.(Pro550Ala),c.1648C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger Taq Man ,UNKNOWN,Symptomatic Non symptomatic ,Crohn's disease ,Canada/,--,2012-07-23,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 7,0.561,1
O15553_Glu552Asp,MEFV,E552D,p.(Glu552Asp),c.1656G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,UNKNOWN,Symptomatic ,PAPA ,Lebanon/Arab,--,2017-08-16,Merlin E  Sarrabay G  Rittore C  Touitou I   Personal communication,Exon 7,0.632,1
O15553_Ile591Thr,MEFV,I591T,p.(Ile591Thr),c.1772T>C,substitution,1,T>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,creates BseNI actgg,Symptomatic ,PAAD-FMF (with criteria) ,France/,--,2001-12-22,Cattan  D  Throo  E  Touitou  I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11464238,Exon 9,0.913,1
O15553_Ala595Val,MEFV,A595V,p.(Ala595Val),c.1784C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,United kingdom/,--,2008-02-25,Russell TL  Rowczenio DM  Lachmann HJ  Hawkins PN    Personal communication,Exon 9,0.843,1
O15553_Asn599Asp,MEFV,N599D,p.(Asn599Asp),c.1795A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,400,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Jordan/Arab,--,2009-06-04,Kohilan A  El-Shanti H   Personal communication,Exon 10,0.862,1
O15553_Ile640Met,MEFV,I640M,p.(Ile640Met),c.1920C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Spain/,Heterozygous compound with R653H mutation,2003-08-01,Aldea  A  Arstegui  JI  Espaol  T  Yage  J   Personal communication,Exon 10,0.684,1
O15553_Ile641Phe,MEFV,I641F,p.(Ile641Phe),c.1921A>T,substitution,1,A>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,1498,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Turkey/,"mutation was found in homozygote status  I641 conserved among higher mammals (homo, pan, canis)",2005-12-29,Haverkamp  T  Paralyova  L   Personal communication,Exon 10,0.734,1
O15553_Pro646Leu,MEFV,P646L,p.(Pro646Leu),c.1937C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Arthritis ,India/,--,2002-08-22,Bybee A  Lachmann H  Booth D  Hawkins P   Personal communication,Exon 10,0.902,1
O15553_Leu649Pro,MEFV,L649P,p.(Leu649Pro),c.1946T>C,substitution,1,T>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Arthritis ,India/,--,2002-08-22,Bybee A  Lachmann H  Booth D  Hawkins P   Personal communication,Exon 10,0.844,1
O15553_Arg652Cys,MEFV,R652C,p.(Arg652Cys),c.1954C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-03-25,Berdeli  A  Demirel  I  Tigli  D  Atan  M   Personal communication,Exon 10,0.806,1
O15553_Arg652His,MEFV,R652H,p.(Arg652His),c.1955G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Crohn's disease ,Canada/,--,2012-07-23,Villani AC et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19784369,Exon 10,0.406,0
O15553_Arg653Ser,MEFV,R653S,p.(Arg653Ser),c.1957C>A,substitution,1,C>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,Portugal/Unknown,--,2019-05-13,Pyram  M  Rittore  C  Tharreau  M  Boursier  G  Touitou  I   Personal communication,Exon 10,0.901,1
O15553_Arg653His,MEFV,R653H,p.(Arg653His),c.1958G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,France/Maghrebian,--,2001-12-22,Aksentijevich  I   Personal communication,Exon 10,0.911,1
O15553_Gly678Glu,MEFV,G678E,p.(Gly678Glu),c.2033G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,United kingdom/,--,2001-12-22,"Lachmann  H et al   Congress abstract:II International Familial Mediterranean Conference, Antalya, Turkey, May 2000",Exon 10,0.9,1
O15553_Thr681Ile,MEFV,T681I,p.(Thr681Ile),c.2042C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,France/Maghrebian,--,2001-12-22,Booth  D et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10024914,Exon 10,0.926,1
O15553_Glu685Lys,MEFV,E685K,p.(Glu685Lys),c.2053G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2014-11-25,Coskun Salih  Ece Aydin  Cim Abdullah  Uluca Unal   Personal communication,Exon 10,0.915,1
O15553_Glu698Asp,MEFV,E698D,p.(Glu698Asp),c.2094G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,destroys RsaI gt/ac,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2014-10-03,Galozzi P  Greco E  Moz S  Basso D  Sfriso P  Plebani M  Punzi L   Personal communication,Exon 10,0.929,1
O15553_Ser702Cys,MEFV,S702C,p.(Ser702Cys),c.2105C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,/,--,2006-07-17,Goulielmos  GN et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16730661,Exon 10,0.93,1
O15553_Arg708Cys,MEFV,R708C,p.(Arg708Cys),c.2122C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,FMF atypical ,/Caucasian,--,2008-11-14,MARCQ L FABRE A TOUITOU I   Personal communication,Exon 10,0.923,1
O15553_Arg717His,MEFV,R717H,p.(Arg717His),c.2150G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Turkey/,--,2011-08-06,"Gulay Ozgon  Aynur Engin  Gulen Hatemi  Elif Akyayla  Serdal U&#287 urlu  Mehmet Bak&#305 r  Huri Ozdogan   Congress abstract:FOUR NOVEL MEFV GENE MUTATIONS IN A POPULATION WHERE THE PREVALENCE OF CRIMEAN-CONGO HEMORRHAGIC FEVER AND MEFV GENE CARRIER STATUS IS VERY HIGH, Istanbul, Turkey, Feb 2011",Exon 10,0.742,1
O15553_Arg717Leu,MEFV,R717L,p.(Arg717Leu),c.2150G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,PFAPA ,Italy/Caucasian,--,2011-09-01,Gattorno M et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19786432,Exon 10,0.922,1
O15553_Ile720Met,MEFV,I720M,p.(Ile720Met),c.2160C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,RFLP Sequencing Sanger ,creates NlaIII catg/,Symptomatic ,UNKNOWN,Jordan/,--,2002-01-29,Medlej-Hashim M  Salem N  Chouery E  Rawashdeh M  Delague V  Haffar M  Mansour I  Naman R  Lefranc G  Loiselet J  Mégarbané A   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11903360,Exon 10,0.901,1
O15553_Val722Met,MEFV,V722M,p.(Val722Met),c.2164G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,700,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Lebanon/,--,2008-11-06,Corbani S  Salem  N  Jalkh  N  Chouery  E  Medelj-Hashim  M   Personal communication,Exon 10,0.715,1
O15553_Ile729Val,MEFV,I729V,p.(Ile729Val),c.2185A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAAD-FMF (with criteria) ,Turkey/Caucasian,--,2013-02-15,Berdeli A  Atan M Tigli D Demirel I.   Personal communication,Exon 10,0.889,1
O15553_Ile729Met,MEFV,I729M,p.(Ile729Met),c.2187C>G,substitution,1,C>G,Uncertain significance (VUS),--,UNKNOWN,YES,Cell free system  Other  ,Altered regulation  Altered regulation  ,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,Castelman,Japan/Asian,--,--,--,Exon 10,0.807,1
O15553_Ala744Ser,MEFV,A744S,p.(Ala744Ser),c.2230G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,ARMS DGGE Sequencing Sanger ,NO,Symptomatic ,PAAD-FMF (with criteria) ,France/Maghrebian,Quite typical of Maghreb,2001-12-24,Bernot et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/9668175,Exon 10,0.88,1
O15553_Ala744Asp,MEFV,A744D,p.(Ala744Asp),c.2231C>A,substitution,1,C>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Marcel syndrome,France/Caucasian,--,2020-12-08,Soria A  Georgin-Lavialle S  Rittore C  Sarrbay G  Boursier G  Touitou I   Personal communication,Exon 10,0.469,0
O15553_Ser749Cys,MEFV,S749C,p.(Ser749Cys),c.2246C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,3000,DGGE Sequencing Sanger ,NO,Symptomatic ,FMF atypical ,France/,--,2007-01-08,Schieffer  F  Dumont  B  Fabre  A  Touitou  I   Personal communication,Exon 10,0.924,1
O15553_Ile755Val,MEFV,I755V,p.(Ile755Val),c.2263A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,Unknown  ,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Netherlands/Caucasian,--,2008-08-05,van Gijn  ME   Personal communication,Exon 10,0.931,1
O15553_Gln778Leu,MEFV,Q778L,p.(Gln778Leu),c.2333A>T,substitution,1,A>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Turkey/,--,2011-08-01,"Gulay Ozgon  Aynur Engin  Gulen Hatemi  Elif Akyayla  Serdal U&#287 urlu  Mehmet Bak&#305 r  Huri Ozdogan   Congress abstract:FOUR NOVEL MEFV GENE MUTATIONS IN A POPULATION WHERE THE PREVALENCE OF CRIMEAN-CONGO HEMORRHAGIC FEVER AND MEFV GENE CARRIER STATUS IS VERY HIGH, Istanbul, Turkey, 17 Feb 2011",Exon 10,0.935,1
O43586_Thr20Met,PSTPIP1,T20M,p.(Thr20Met),c.59C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic Non symptomatic ,Undefined-AID ,France/Mediterranean,"In another individual, inherited from an asymptomatic parent.",2019-05-13,Lamireau  T  Mechin  D  Sarrabay  G  Touitou  I   Personal communication,Exon 2,0.528,1
O43586_Lys34Thr,PSTPIP1,K34T,p.(Lys34Thr),c.101A>C,substitution,1,A>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,Japan/,No clinical informations,2019-10-02,Nakayama M  Ohara O   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28956000,Exon 2,0.262,0
O43586_Ala49Val,PSTPIP1,A49V,p.(Ala49Val),c.146C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID Vasculitis,France/,--,2019-05-13,Geneviève  D  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.24,0
O43586_Glu51Asp,PSTPIP1,E51D,p.(Glu51Asp),c.153G>T,substitution,1,G>T,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Unknown,RA,India/,--,2019-08-21,Kumar BS et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27184502,Exon 3,0.477,0
O43586_Arg52Gln,PSTPIP1,R52Q,p.(Arg52Gln),c.155G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,600,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic Non symptomatic ,Pyoderma gangrenosum,/,"This variant does not map within any of  the key functional domains of CD2BP1 and does not alter transcript splicing. Although this variant  was only present in 1 of 600 ethnically matched healthy controls, it is predicted to be biologically silent by an in silico  algorithm (PolyPhen)",2012-03-02,Newman et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15102098,Exon 3,0.577,1
O43586_Leu57Arg,PSTPIP1,L57R,p.(Leu57Arg),c.170T>G,substitution,1,T>G,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Unknown,RA,India/,--,2019-08-21,Kumar BS et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27184502,Exon 3,0.58,1
O43586_Arg62Trp,PSTPIP1,R62W,p.(Arg62Trp),c.184C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/,--,2019-05-13,Attout  H  Dumont  B  Sarrabay  G Touitou  I   Personal communication,Exon 3,0.64,1
O43586_Ala64Thr,PSTPIP1,A64T,p.(Ala64Thr),c.190G>A,substitution,1,G>A,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Unknown,RA,India/,--,2019-08-21,Kumar BS et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27184502,Exon 3,0.455,0
O43586_Glu110Asp,PSTPIP1,E110D,p.(Glu110Asp),c.330G>C,substitution,1,G>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 5,0.592,1
O43586_Arg202Trp,PSTPIP1,R202W,p.(Arg202Trp),c.604C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Russian federation/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 9,0.416,0
O43586_Gly258Arg,PSTPIP1,G258R,p.(Gly258Arg),c.772_774delinsAGG,delins,3 deleted/3 inserted,GGC / AGG,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,Italy/,"Recurrent fever episodes, every 15-20 days, with exudative pharyngitis, cervical lymphadenopathy, abdominal pain and arthralgia. Partial response to colchicine",2019-10-02,Papa R  Ceccherini I  Gattorno M   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/31325311,Exon 11,0.558,1
O43586_Asp266Asn,PSTPIP1,D266N,p.(Asp266Asn),c.796G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,206,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAPA ,Spain/,--,2006-05-22,Arostegui JI  Cid MC  Yague J   Personal communication,Exon 11,0.469,0
O43586_Thr274Met,PSTPIP1,T274M,p.(Thr274Met),c.821C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,YES,Culture studies  ,less responsive effect to T-cell activation through altered F-actin polymerization  ,--,Unknown ,--,Symptomatic ,Otulin-AID Common Variable Immune Deficiency (CVID),Czech republic/,According to the publication : CVID presenting with aberrant T-cell compartments but with no classical PAPA or FMF syndrome,2019-10-02,Janssen W  Boes M   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/?term=29432774,Exon 11,0.49,0
O43586_Asp289His,PSTPIP1,D289H,p.(Asp289His),c.865G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2016-11-23,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano  María Francisca González-Escribano  et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 12,0.376,0
O43586_Ser323Leu,PSTPIP1,S323L,p.(Ser323Leu),c.968C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 13,0.551,1
O43586_Ala329Val,PSTPIP1,A329V,p.(Ala329Val),c.986C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Familial urticaria,France/,--,2019-05-13,Pagnier  A   Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 14,0.351,0
O43586_Val344Ile,PSTPIP1,Val344Ile,p.(Val344Ile),c.1030G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Netherlands/Caucasian,--,2008-12-01,van Gijn  ME   Personal communication,Exon 14,0.404,0
O43586_Arg365Trp,PSTPIP1,R365W,p.(Arg365Trp),c.1093C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,PAPA ,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 14,0.369,0
O43586_Asp369Gly,PSTPIP1,D369G,p.(Asp369Gly),c.1106A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,Japan/,No clinical informations,2019-10-02,Nakayama M  Ohara O   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28956000,Exon 14,0.022,0
O43586_Ile385Thr,PSTPIP1,c.1154T>C,p.(Ile385Thr),c.1154T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/,--,2019-03-27,Boursier G  Vautier M  Rittore C  Touitou I   Personal communication,Exon 15,0.517,1
O43586_Gly403Arg,PSTPIP1,G403R,p.(Gly403Arg),c.1207G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,PAPA ,/,"frequency 1 of 8,380 EU chromosomes as given in the  exome variant server (EVS)",2015-02-17,Zeeli T et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/25683018,Exon 15,0.529,1
O43586_Gly403Glu,PSTPIP1,G403E,p.(Gly403Glu),c.1208G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic Non symptomatic ,CAPS ,France/Caucasian,"This variant is reported in the EXAC database, with allele frequency .0002389",2015-12-23,Retornaz K Dumont B Sarrabay G Touitou I   Personal communication,Exon 15,0.496,0
O43586_Val408Ile,PSTPIP1,V408I,p.(Val408Ile),c.1222G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 15,0.677,1
P16885_Asp59Gly,PLCG2,D59G,p.(Asp59Gly),c.176A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Fischbach  M  Dumont  B     Personal communication,Exon 2,0.394,0
P16885_Ile169Val,PLCG2,I169V,p.(Ile169Val),c.505A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,India/Asian,--,2019-05-13,Sawhney  S  Fabre  A  Mechin  D  Sarrabay  G  Touitou  I   Personal communication,Exon 6,0.589,1
P16885_His193Gln,PLCG2,H193Q,p.(His193Gln),c.579C>G,substitution,1,C>G,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,Undefined-AID ,"Iran, islamic republic of/",This missense variant is recessively inherited. The associated phenotype is not consistent with typical denovo/AD mutations associated with APLAID,2020-04-02,Khabbazi A et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/32014489,Exon 7,0.506,1
P16885_Ser216Leu,PLCG2,S216L,p.(Ser216Leu),c.647C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 7,0.519,1
P16885_Val227Met,PLCG2,V227M,p.(Val227Met),c.679G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Caucasian,Juvenil arthritis and uveitis (Blau sd suspected),2020-07-01,Miceli C  Rittore C  Boursier G  Touitou I   Personal communication,Exon 8,0.556,1
P16885_Pro236Leu,PLCG2,P236L,p.(Pro236Leu),c.707C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Vasculitis,Spain/Mediterranean,--,2019-05-13,Cohen Aubart  F  Sarrabay  G  Touitou  I   Personal communication,Exon 9,0.322,0
P16885_Ile509Thr,PLCG2,I509T,p.(Ile509Thr),c.1526T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Undefined-AID ,France/,"In another individual, inherited from an asymptomatic parent.",2019-05-13,Echaubard  S  Sarrabay  G  Touitou  I   Personal communication,Exon 16,0.48,0
P16885_Glu721Lys,PLCG2,E721K,p.(Glu721Lys),c.2161G>A,substitution,1,G>A,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Symptomatic ,Undefined-AID ,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 20,0.247,0
P16885_Arg956Cys,PLCG2,R956C,p.(Arg956Cys),c.2866C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,CVID,/,This patient is a 40-year-old male with idiopathic thrombocytopenia in childhood and severe pneumococcal meningitis at the age of 34 years. The pathogenicity of this variant is not confirmed by functional analysis. ,2020-04-02,Christiansen M et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/32047491,Exon 27,0.48,0
P16885_Ala1130Ser,PLCG2,A1130S,p.(Ala1130Ser),c.3388G>T,substitution,1,G>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,PLCG2-AID (APLAID) ,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 30,0.767,1
P19438_Val20Ala,TNFRSF1A,c.59T>C,p.(Val20Ala),c.59T>C,substitution,1,T>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,United states/Caucasian,--,2011-08-24,Yao  QP Yerian  L Shen  B   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed?term=yao%20and%20v20a,Exon 2,0.874,1
P19438_Asp41Glu,TNFRSF1A,D12E,p.(Asp41Glu),c.123T>G,substitution,1,T>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,400,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Italy/,--,2006-03-09,D'Osualdo et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16508982,Exon 2,0.67,1
P19438_Lys48Ile,TNFRSF1A,K19I,p.(Lys48Ile),c.143A>T,substitution,1,A>T,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Unknown ,--,Symptomatic ,TRAPS ,Italy/,--,--,--,Exon 2,0.568,1
P19438_Asn54Asp,TNFRSF1A,N25D,p.(Asn54Asp),c.160A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,Japan/Asian,The sequence and/or protein name of this variant has been edited as compared to that in the initial publication,2011-09-02,Nakamura M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20400394,Exon 2,0.91,1
P19438_Ile57Ser,TNFRSF1A,I28S,p.(Ile57Ser),c.170T>G,substitution,1,T>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,United kingdom/Caucasian,--,2012-07-03,Rowczenio DM  Trojer H  Lachmann HJ  Hawkins PN    Personal communication,Exon 2,0.891,1
P19438_Pro75Leu,TNFRSF1A,P46L,p.(Pro75Leu),c.224C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,326,Sequencing Sanger ,creates StuI agg/cct,Symptomatic ,TRAPS ,Unknown/,impaired TNFRSF1A shedding - Low penetrance mutation,2002-03-18,Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543,Exon 3,0.545,1
P19438_Gln77His,TNFRSF1A,Q77H,p.(Gln77His),c.231G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Tunisia and France,--,2019-05-13,Soler C Rittore C Imbert-Bouteille M Sarrabay G Bouriser G Touitou I   Personal communication,Exon 3,0.54,1
P19438_Arg82Gly,TNFRSF1A,R53G,p.(Arg82Gly),c.244A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,TRAPS ,Italy/Caucasian,--,2013-08-16,Gattorno M  Ceccherini I   Personal communication,Exon 3,0.172,0
P19438_Thr90Ile,TNFRSF1A,T61I,p.(Thr90Ile),c.269C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,destroys HphI ggtga,Symptomatic ,Systemic Lupus Erythematosus ,Japan/,--,2004-08-05,Ida H  Kawasaki E  Miyashita T  Tanaka F  Kamachi M  Izumi Y  Huang M  Tamai M  Origuchi T  Kawakami A  Migita K  Motomura M  Yoshimura T  Eguchi K   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15280569,Exon 3,0.719,1
P19438_Gln111Lys,TNFRSF1A,Q82K,p.(Gln111Lys),c.331C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,1376,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,United states/Caucasian,--,2010-07-27,Overman  L   Personal communication,Exon 4,0.89,1
P19438_Thr118Ala,TNFRSF1A,T89A,p.(Thr118Ala),c.352A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,345,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS TRAPS/HIDS overlapping phenotype,United states/Caucasian,--,2010-04-06,Saulsbury FT et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20346247,Exon 4,0.427,0
P19438_Arg121Gln,TNFRSF1A,R92Q,p.(Arg121Gln),c.362G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,destroys NciI cc/sgg,Symptomatic ,Early Arthritis TRAPS ,European populations/Caucasian,normal TNFRSF1A shedding - Low penetrance mutation,2002-01-25,Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543,Exon 4,0.582,1
P19438_Asp122Glu,TNFRSF1A,D93E,p.(Asp122Glu),c.366C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,Netherlands/Netherlands,--,2013-05-06,Marielle Van Gijn   Personal communication,Exon 4,0.604,1
P19438_Arg133Gln,TNFRSF1A,R104Q,p.(Arg133Gln),c.398G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,200,Sequencing Sanger SSCP ,UNKNOWN,Unknown,Systemic Lupus Erythematosus ,Japan/,"R104Q was found in 2 out of 100 Japanese unrelated SLE patients, which was not identified in 100 Japanese RA patients or 100 control subjects. ",2004-10-25,Horiuchi T et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15492850,Exon 4,0.957,1
P19438_His134Pro,TNFRSF1A,H105P,p.(His134Pro),c.401A>C,substitution,1,A>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,Germany/,--,2007-07-09,"Wendling D et al   Congress abstract:FMF2005, Bethesda, USA, November 2005",Exon 4,0.361,0
P19438_Asn145Ser,TNFRSF1A,N116S,p.(Asn145Ser),c.434A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Turkey/,--,2008-08-05,van Gijn  ME   Personal communication,Exon 4,0.621,1
P19438_Lys161Arg,TNFRSF1A,K161R,p.(Lys161Arg),c.482A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Mediterranean,Recurrent pericarditis and pneumonia,2019-11-08,Leroux G  Rittore C  Boursier G  Touitou I   Personal communication,Exon 5,0.684,1
P19438_Val165Met,TNFRSF1A,V136M,p.(Val165Met),c.493G>A,substitution,1,G>A,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Symptomatic ,TRAPS ,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 5,0.744,1
P19438_Ser226Cys,TNFRSF1A,S197C,p.(Ser226Cys),c.677C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS ,Turkey/Caucasian,"A 61 year old Turkish female. She has had rare polyarticular arthritic attacks since age 12.  She has been experiencing attacks of fever, periorbital edema and maculopapular skin rashes on her face,neck and arms lasting more than 2 weeks, since age of 53. Some of her attacks accompany with polarticular arthritis. Her attacks partially responded to methyl prednisolone treatment.She has been diagnosed as Primary Sjögren's Syndrome as well, since age of 57, which was proven by minor lacrimal gland biopsy.",2011-10-13,Erken E  Dinkci S  Eroglu A  Yildiz F   Personal communication,Exon 7,0.765,1
P19438_Ser350Ile,TNFRSF1A,S321I,p.(Ser350Ile),c.1049G>T,substitution,1,G>T,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger ,--,Symptomatic ,TRAPS ,Japan/Asian,--,2019-07-11,Ueda N et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/27332769,Exon 9,0.514,1
P19438_Pro448Leu,TNFRSF1A,P448L,p.(Pro448Leu),c.1343C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,CVID,Denmark/,--,2020-04-02,Christiansen M et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/32047491,Exon 10,0.314,0
P21580_Arg22Gln,TNFAIP3,R22Q,p.(Arg22Gln),c.65G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Chronic urticaria and angiooedema,Italy/Hispanic,--,2018-03-05,Harris A et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/29682366,Exon 2,0.65,1
P21580_Asn102Ser,TNFAIP3,N102S,p.(Asn102Ser),c.305A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,YES,Culture studies  ,Altered regulation  ,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,TNFAIP3-AID (HA20) ,China/Asian,--,2020-08-28,Chen Y et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/32719680,Exon 3,0.785,1
P21580_Arg141Cys,TNFAIP3,R141C,p.(Arg141Cys),c.421C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Behçet's disease ,Italy/Caucasian,--,2019-05-13,Guyon G Rittore C Ruault V  Boursier G Touitou I   Personal communication,Exon 3,0.607,1
P21580_Thr155Met,TNFAIP3,T155M,p.(Thr155Met),c.464C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,TNFAIP3-AID (HA20) ,France/Caucasian,--,2019-03-18,"Borocco C Sarrabay S Boursier G Artru S Palluy H Touitou I Kone-Paut I   Congress abstract:ISSAID2019,Genova, Italy, 30/03/2019-3/04/2019",Exon 3,0.436,0
P21580_Ala175Pro,TNFAIP3,A175P,p.(Ala175Pro),c.523G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic Non symptomatic ,TNFAIP3-AID (HA20) ,France/Caucasian,Complex aphthosis  Inherited from an asymptomatic father,2020-09-30,Knapke A  Rittore C  Sarrabay G  Boursier G  Touitou I   Personal communication,Exon 4,0.942,1
P21580_Thr292Pro,TNFAIP3,T292P,p.(Thr292Pro),c.874A>C,substitution,1,A>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,TNFAIP3-AID (HA20) ,France/,--,2019-05-13,Lemelle I Rittore C Imbert-Bouteille M Sarrabay G Touitou I   Personal communication,Exon 6,0.944,1
P21580_Asp384Gly,TNFAIP3,D384G,p.(Asp384Gly),c.1151A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Lemelle I Rittore C Philibert L  Sarrabay G Touitou I   Personal communication,Exon 7,0.885,1
P21580_Trp448Cys,TNFAIP3,W448C,p.(Trp448Cys),c.1344G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,Egypt/Mediterranean,--,2019-05-13,Soler C Rittore C Rama M Bouriser G Sarrabay G Touitou I   Personal communication,Exon 7,0.198,0
P21580_Thr647Pro,TNFAIP3,T647P,p.(Thr647Pro),c.1939A>C,substitution,1,A>C,Uncertain significance (VUS),--,UNKNOWN,YES,Culture studies  ,Altered regulation  ,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,TNFAIP3-AID (HA20) ,Pakistan/Indian,--,2019-06-12,Yiping Liu  Zhan Ye  Xiang Li  Jennifer L Anderson  Mike Khan  Douglas DaSilva  1   Marissa Baron  Deborah Wilson  Vera Bocoun  Lynn C Ivacic  Steven J Schrodi   Judith A Smith   Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/28791018/,Exon 8,0.946,1
P21580_Ile679Thr,TNFAIP3,I679T,p.(Ile679Thr),c.2036T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Behçet's disease ,France/Mediterranean,--,2019-05-13,Soler C Rittore C Sarrabay G Touitou I   Personal communication,Exon 8,0.26,0
P25788_Ala147Thr,PSMA3,A147T,p.(Ala147Thr),c.439G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Soler  C  Rittore  C  Dumopnt  B  Sarrabay  G  Touitou  I   Personal communication,Exon 6,0.684,1
P28062_Thr74Ser,PSMB8,T74S,p.(Thr74Ser),c.220A>T,substitution,1,A>T,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,CANDLE Syndrome,Italy/Caucasian,--,2012-09-05,Insalaco A.   Personal communication,Exon 2,0.705,1
P28062_Phe80Leu,PSMB8,F80L,p.(Phe80Leu),c.240C>G,substitution,1,C>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Hachulla  E  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 2,0.741,1
P28062_Tyr234Cys,PSMB8,Y234C,p.(Tyr234Cys),c.701A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,France/,--,2019-05-13,Ruivard  M  Rama  M  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.57,1
P28065_Val32Ile,PSMB9,V32I,p.(Val32Ile),c.94G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 2,0.287,0
P28065_Arg60Cys,PSMB9,R60C,p.(Arg60Cys),c.178C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Melki  I Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.539,1
P28065_Arg173Cys,PSMB9,R173C,p.(Arg173Cys),c.517C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Konate  A  Rittore  C  Tharreau  M  Boursier  G  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.253,0
P28070_Gly15Arg,PSMB4,G15R,p.(Gly15Arg),c.43G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,Madagascar/African,--,2019-05-13,Sailler  L  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 1,0.959,1
P59046_Asn144Ser,NLRP12,N144S,p.(Asn144Ser),c.431A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Undefined-AID ,France/Caucasian,--,2019-05-13,Faisant  A  Rittore  C  Rama  M  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.617,1
P59046_Arg146His,NLRP12,R146H,p.(Arg146His),c.437G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,Algeria/,--,2019-05-13,Branger  S  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.61,1
P59046_Pro286Leu,NLRP12,P286L,p.(Pro286Leu),c.857C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,Spain/,--,2019-05-13,Maurier  F  Dumont B  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.457,0
P59046_Arg370Lys,NLRP12,c.1109G>A,p.(Arg370Lys),c.1109G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/,--,2019-03-27,Boursier G  Remy-Piccolo V  Rittore C  Touitou I   Personal communication,Exon 3,0.496,0
P59046_Pro404Leu,NLRP12,P404L,p.(Pro404Leu),c.1211C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Caucasian,--,2019-05-13,Merlin  E  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.464,0
P59046_Leu439Gln,NLRP12,L439Q,p.(Leu439Gln),c.1316T>A,substitution,1,T>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Recurrent fever,/,--,2019-05-13,Pagnier  A  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.759,1
P59046_Arg482Trp,NLRP12,R482W,p.(Arg482Trp),c.1444C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Recurrent fever,/,--,2019-05-13,Beucher  AB  Rittore  C  Rama  M  Sarrabay  G  Touitou  I   Personal communication,Exon 3,0.551,1
P59046_Glu507Lys,NLRP12,E507K,p.(Glu507Lys),c.1519G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,Periodic fever,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 3,0.654,1
P59046_Tyr509Ter,NLRP12,Y509X,p.(Tyr509Ter),c.1527C>A,substitution,1,C>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 3,0.453,0
P59046_Ala549Thr,NLRP12,A549T,p.(Ala549Thr),c.1645G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Familial urticaria,France/Mediterranean,--,2019-12-19,Poreau B  Thevenon J  Rittore C  Boursier G  Touitou I   Personal communication,Exon 3,0.579,1
P59046_Asn712Ser,NLRP12,N712S,p.(Asn712Ser),c.2135A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Behçet's disease ,France/,bipolar aphtosis,2020-07-01,Lhome R  Rittore C  Boursier G  Touitou I   Personal communication,Exon 4,0.62,1
P59046_Arg753His,NLRP12,R753H,p.(Arg753His),c.2258G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,NLRP12-AID ,Germany/Caucasian,--,2020-04-22,Blank N   Personal communication,Exon 5,0.442,0
P59046_Glu840Gln,NLRP12,E840Q,p.(Glu840Gln),c.2518G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,Senegal/,--,2019-05-13,London  J  Rittore  C   Ruault  V  Boursier  G  Touitou  I   Personal communication,Exon 6,0.61,1
P59046_Asn940Ser,NLRP12,N940S,p.(Asn940Ser),c.2819A>G,substitution,1,A>G,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,NLRP12-AID ,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 8,0.541,1
P78314_Arg80Gln,SH3BP2,R80Q,p.(Arg80Gln),c.239G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,Variant was detected in several patients with systemic autoinflammatory disease (SAID) with different phenotypes. Allele frequency of 0.005619 in ExAc database.,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 3,0.706,1
P78314_Gly313Arg,SH3BP2,G313R,p.(Gly313Arg),c.937G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,France/,Found in 2 patients with systemic autoinflammatory disease (SAID) without cherubism phenotype. Variant is classified as variant of unknown significance (VOUS) by ACMG because of low frequency in databases and with discordant in-silico predictions.,2019-05-13,Sigur  N  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 8,0.513,1
P78314_Val542Met,SH3BP2,V542M,p.(Val542Met),c.1624G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Castros  F  Rittore  C  Boursier  G  Sarrabay  G  Touitou  I   Personal communication,Exon 13,0.6,1
P78314_Ser545Asn,SH3BP2,S545N,p.(Ser545Asn),c.1634G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,PFAPA ,Greece/Mediterranean,Found in 1 patient with systemic autoinflammatory disease (SAID) without cherubism phenotype. Variant is classified as variant of unknown significance (VOUS) by ACMG because of low frequency in databases and with discordant in-silico predictions.,2019-05-13,Marsaud  C  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 13,0.525,1
Q03426_Val5Ala,MVK,V5A,p.(Val5Ala),c.14T>C,substitution,1,T>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,100,Sequencing Sanger HRM ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,France/Maghrebian,--,2010-08-26,Garnier JM  Dumont B  Barat-Houari M  Touitou I   Personal communication,Exon 2,0.963,1
Q03426_Ile56Val,MVK,I56V,p.(Ile56Val),c.166A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Italy/,--,2013-08-16,Ceccherini I   Personal communication,Exon 3,0.191,0
Q03426_Pro127Leu,MVK,P127L,p.(Pro127Leu),c.380C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,400,Sequencing Sanger ,NO,Symptomatic ,NLRP3-AID-moderate (MWS) ,Spain/Caucasian,R260W mutation (p.Arg260Trp) in the NLRP3 gene was found in this patient confirming the clinical diagnosis of MUCKLE-WELLS syndrome. One additional change heterozygous P127L was also found in MVK gene.,2014-02-24,Basagaña M  Mendez M  Ruiz-Ortiz E  Gonzalez-Roca  E  Yague J  Arostegui  Juan I   Personal communication,Exon 5,0.585,1
Q03426_Asp130Gly,MVK,D130G,p.(Asp130Gly),c.389A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,/,--,2019-05-13,Agard  C  Rittore  C  Tharreau  M  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.202,0
Q03426_Glu180Lys,MVK,E180K,p.(Glu180Lys),c.538G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,/,--,2019-05-21,Karacan I   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/30783801,Exon 6,0.709,1
Q03426_Asp204Glu,MVK,D204E,p.(Asp204Glu),c.612C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,France/Caucasian,--,2012-02-20,Cuisset  L  Duquesne A   Personal communication,Exon 6,0.199,0
Q03426_Arg215Gly,MVK,R215G,p.(Arg215Gly),c.643C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,DSAP ,China/,--,2014-03-10,Lu WS et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/24551296,Exon 7,0.792,1
Q03426_Asn252Ser,MVK,N252S,p.(Asn252Ser),c.755A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,South Africa/,--,2013-08-16,Scott C  Gattorno M  Ceccherini I   Personal communication,Exon 8,0.795,1
Q03426_Leu255Pro,MVK,L255P,p.(Leu255Pro),c.764T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,676,Sequencing Sanger ,UNKNOWN,Symptomatic ,DSAP ,China/,--,2013-02-05,Zhang SQ et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22983302,Exon 8,0.813,1
Q03426_Asp269His,MVK,D269H,p.(Asp269His),c.805G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,2788,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Turkey/,--,2012-01-30,Lainka E and Lohse P et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22038276,Exon 9,0.907,1
Q03426_Pro286Leu,MVK,P286L,p.(Pro286Leu),c.857C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,Ireland/,--,2008-02-26,Russell TL  Rowczenio DM  Lachmann HJ  Hawkins PN   Personal communication,Exon 9,0.321,0
Q03426_Pro288Leu,MVK,P288L,p.(Pro288Leu),c.863C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,Italy/,--,2006-05-02,D'Osualdo A. and Ceccherini I.   Personal communication,Exon 9,0.546,1
Q03426_Gln290His,MVK,Q290H,p.(Gln290His),c.870G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Mediterranean,Suspected MKD but this variant was found heterozygous. No mevalonaturia tested.,2019-11-08,Rousselin C  Rittore C  Boursier G  Touitou I   Personal communication,Exon 9,0.947,1
Q03426_Val293Met,MVK,V293M,p.(Val293Met),c.877G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,Italy/,--,2006-05-02,D'Osualdo A. and Ceccherini I.   Personal communication,Exon 9,0.259,0
Q03426_Leu315Val,MVK,L315V,p.(Leu315Val),c.943C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Unknown ,UNKNOWN,Unknown,MKD undefined,/,--,2013-02-05,Toplak N et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22377804,Exon 10,0.865,1
Q03426_Thr356Met,MVK,T356M,p.(Thr356Met),c.1067C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,Italy/,--,2004-12-16,D'Osualdo et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15536479,Exon 11,0.687,1
Q03426_Cys367Ser,MVK,C367S,p.(Cys367Ser),c.1100G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,Italy/,--,2006-05-02,D'Osualdo A. and Ceccherini I.   Personal communication,Exon 11,0.786,1
Q03426_Ile372Met,MVK,I372M,p.(Ile372Met),c.1116C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,TRAPS like,Italy/,--,2013-08-30,Gattorno M Ceccherini I   Personal communication,Exon 11,0.658,1
Q03426_Ala382Pro,MVK,A382P,p.(Ala382Pro),c.1144G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,"Behçet's disease A 46 year old Turkish female, who has been suffering from Behçet&#8217;s Disease (BD) symptoms for 10 years. She has been diagnosed as BD at the age of 40 with the findings of oral aphthous lesions, genital ulcers and uveitis. She has been on colchicine for 10 years and her uveitis was treated with Cyclosporin for 3 years. She has no history of recurrent fever and abdominal pain. Her exon 10 MEFV mutation analysis is negative. Exon 2 sequence analysis revealed heterozygous E148Q variant.",Turkey/Caucasian,--,2012-12-03,Erken E  Dinkci S  Eroglu A  Arslan Tas Didem    Personal communication,Exon 11,0.535,1
Q03426_Ser384Phe,MVK,S384F,p.(Ser384Phe),c.1151C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger HRM ,UNKNOWN,Symptomatic ,Recurrent Fever ,France/Caucasian,--,2009-10-16,Retornaz K. Fabre A  Touitou I   Personal communication,Exon 11,0.67,1
Q03426_Asp386Asn,MVK,D386N,p.(Asp386Asn),c.1156G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,MKD-mild (HIDS) ,India/,--,2008-02-26,Russell TL  Rowczenio DM  Lachmann HJ  Hawkins PN   Personal communication,Exon 11,0.847,1
Q13546_Cys325Arg,RIPK1,C325R,p.(Cys325Arg),c.973T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Mediterranean,"recurrent fever, HSM, lymphadenopathy, abdominal pain, pharyngitis, myalgia since 6 months of life",2020-06-05,Quartier P  Rittore C  Boursier G  Touitou I   Personal communication,Exon 8,0.353,0
Q86WV6_Arg94His,STING1,R94H,p.(Arg94His),c.281G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Caucasian,"Urticaria, arthralgia, bucal aphtosis  Mosaicism (4%)",2020-07-09,Georgin-Lavialle S.  Rittore C.  Boursier G.  Touitou I.   Personal communication,Exon 4,0.658,1
Q8WX94_Cys84Tyr,NLRP7,C84Y,p.(Cys84Tyr),c.251G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,212,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,China/Chinese,Only this mutation in a heterozygous state was found in the patient.,2007-08-15,Slim  R.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19066229,Exon 2,0.92,1
Q8WX94_Asp149Gly,NLRP7,D149G,p.(Asp149Gly),c.446A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209,Exon 4,0.799,1
Q8WX94_Val182Met,NLRP7,V182M,p.(Val182Met),c.544G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,340,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole complete hydatidifom mole,Tunisia/Maghrebian,--,2011-10-30,Landolsi  H  Rittore  C  Philibert  L   Hmissa  S  Gribaa  M  Touitou  I  Yacoubi  MT.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22646272,Exon 4,0.603,1
Q8WX94_Met192Leu,NLRP7,M192L,p.(Met192Leu),c.574A>C,substitution,1,A>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,76,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,UNKNOWN,India/Asian,--,2008-07-11,Slim R   Personal communication,Exon 4,0.318,0
Q8WX94_Leu210Phe,NLRP7,L210F,p.(Leu210Phe),c.628C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Canada/Caucasian,--,2011-03-04,Slim  R   Personal communication,Exon 4,0.527,1
Q8WX94_Leu234Ser,NLRP7,L234S,p.(Leu234Ser),c.701T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,132,RFLP Sequencing Sanger ,creates HinfI g/antc,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole Normal pregnancies ,/Caucasian,--,2010-02-03,Giacobino A Rittore C Touitou I   Personal communication,Exon 4,0.958,1
Q8WX94_Phe250Cys,NLRP7,F250C,p.(Phe250Cys),c.749T>G,substitution,1,T>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,208,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Germany/Caucasian,--,2010-07-22,Slim R   Personal communication,Exon 4,0.949,1
Q8WX94_Phe250Leu,NLRP7,F250L,p.(Phe250Leu),c.750C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,India/Asian,--,2010-04-06,Slim  R   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21659348,Exon 4,0.604,1
Q8WX94_Lys277Gln,NLRP7,K277Q,p.(Lys277Gln),c.829A>C,substitution,1,A>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,Pakistan/Asian,--,2008-07-11,Slim R   Personal communication,Exon 4,0.53,1
Q8WX94_Val279Leu,NLRP7,V279L,p.(Val279Leu),c.835G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209/,Exon 4,0.408,0
Q8WX94_Leu311His,NLRP7,L311H,p.(Leu311His),c.930G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,208,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,France/Caucasian,--,2010-07-22,Slim  R   Personal communication,Exon 4,0.921,1
Q8WX94_Arg329Lys,NLRP7,R329K,p.(Arg329Lys),c.986G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Unknown ,creates AvaII g/gwcc,Non symptomatic ,NO,/,--,2007-11-21,Slim  R   Personal communication,Exon 4,0.388,0
Q8WX94_Glu340Lys,NLRP7,E340K,p.(Glu340Lys),c.1018G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,382,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Spontaneous abortions NLRP7-AID-Non-recurrent hydatiform mole ,Pakistan/Asian,--,2011-01-12,Slim  R   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21659348,Exon 4,0.475,0
Q8WX94_Ile368Met,NLRP7,I368M,p.(Ile368Met),c.1104T>G,substitution,1,T>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Canada/Caucasian,--,2011-01-13,Slim  R   Personal communication,Exon 4,0.148,0
Q8WX94_Gly380Arg,NLRP7,G380R,p.(Gly380Arg),c.1138G>C,substitution,1,G>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,NO,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,Pakistan/Mirpur,--,2009-04-03,Hayward  et al.   Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/19309689/,Exon 4,0.954,1
Q8WX94_Pro383Leu,NLRP7,P383L,p.(Pro383Leu),c.1148C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209/,Exon 4,0.656,1
Q8WX94_Arg390His,NLRP7,R390H,p.(Arg390His),c.1169G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,Senegal/African,--,2009-02-04,Rima Slim   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21659348,Exon 4,0.57,1
Q8WX94_Thr391Ala,NLRP7,T391A,p.(Thr391Ala),c.1171A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209/,Exon 4,0.14,0
Q8WX94_Cys399Tyr,NLRP7,C399Y,p.(Cys399Tyr),c.1196G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,350,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Stillbirth NLRP7-AID-Spontaneous abortions NLRP7-AID-Non-recurrent hydatiform mole Blighted ovum,Morocco/Morrocan,The patient was compound heterozygous for this variant and for G487E.,2007-08-15,Deveault C  Qian JH  Chebaro W  Ao A  Gilbert L  Mehio A  Khan R  Tan SL  Wischmeijer A  Coullin P  Xie X  Slim R.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19066229,Exon 4,0.543,1
Q8WX94_Leu412Pro,NLRP7,L412P,p.(Leu412Pro),c.1235T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209/,Exon 4,0.846,1
Q8WX94_Arg413Trp,NLRP7,R413W,p.(Arg413Trp),c.1237C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,556,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,Haiti/African,--,2011-01-12,Slim  R   Personal communication,Exon 4,0.323,0
Q8WX94_Arg413Gln,NLRP7,R413Q,p.(Arg413Gln),c.1238G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,/Asian,--,2012-02-23,Dixon  PH  Trongwongsa  P  Abu-Hayyah  S  Ng  SH  Akbar  SA  Khawaja  NP  Seckl  MJ  Savage  PM  Fisher  RA   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22315435,Exon 4,0.292,0
Q8WX94_Met427Thr,NLRP7,M427T,p.(Met427Thr),c.1280T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,NO,Symptomatic ,UNKNOWN,Morocco/Maghrebian,--,2009-02-04,Rima Slim   Publication (Medline Abstract): http://uswest.ensembl.org/Homo_sapiens/Gene/Variation_Gene/Table?g=ENSG00000167634,Exon 4,0.229,0
Q8WX94_Phe430Leu,NLRP7,F430L,p.(Phe430Leu),c.1288T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,91,Sequencing Sanger ,NO,Symptomatic Non symptomatic ,UNKNOWN,Morocco/Maghrebian,--,2009-03-03,Slim R   Personal communication,Exon 4,0.613,1
Q8WX94_Ala494Thr,NLRP7,A494T,p.(Ala494Thr),c.1480G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,340,Sequencing Sanger ,UNKNOWN,Symptomatic ,"NLRP7-AID-Non-recurrent hydatiform mole normal pregnancy, spontaneous abortion, partial hydatidiform mole, complete hydatidiform mole",Tunisia/Maghrebian,--,2011-10-30,Landolsi  H  Rittore  C  Philibert  L   Hmissa  S  Gribaa  M  Touitou  I  Yacoubi  MT.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22646272,Exon 4,0.697,1
Q8WX94_Gly498Arg,NLRP7,G498R,p.(Gly498Arg),c.1492G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,Senegal/African,--,2009-02-04,Slim  R   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21948117,Exon 4,0.758,1
Q8WX94_Pro513Ser,NLRP7,P513S,p.(Pro513Ser),c.1537C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,Canada/Caucasian,--,2012-03-07,Slim  R   Personal communication,Exon 4,0.53,1
Q8WX94_Ser608Phe,NLRP7,S608F,p.(Ser608Phe),c.1823C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed?term=Vasseur%20AND%202012%20AND%20The%20Evolutionary%20Landscape,Exon 4,0.965,1
Q8WX94_Leu661Phe,NLRP7,L661F,p.(Leu661Phe),c.1981C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,/Asian,--,2013-10-12,Mahadevan S   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/24105752,Exon 5,0.937,1
Q8WX94_Cys668Arg,NLRP7,C668R,p.(Cys668Arg),c.2002T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,India/Asian,--,2017-11-15,Nguyen et al    Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/29463882,Exon 5,0.953,1
Q8WX94_Ser675Thr,NLRP7,S675T,p.(Ser675Thr),c.2024G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,Senegal/African,--,2009-06-17,Slim  R   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/21948117,Exon 5,0.459,0
Q8WX94_Arg701Cys,NLRP7,R701C,p.(Arg701Cys),c.2101C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,578,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole NLRP7-AID-Spontaneous abortions ,China/Asian,--,2008-07-11,Slim  R   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/19066229,Exon 5,0.482,0
Q8WX94_Val714Ile,NLRP7,V714I,p.(Val714Ile),c.2140G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Non symptomatic ,NO,/,--,2012-10-30,Vasseur  E    Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/22748209/,Exon 6,0.435,0
Q8WX94_Ala719Val,NLRP7,A719V,p.(Ala719Val),c.2156C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,180,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole Normal pregnancies early foetal loss,Italy/Caucasian,Only a single mutation was found in the patient and was inherited from the father.,2008-07-07,Deveault C  Qian JH  Chebaro W  Ao A  Gilbert L  Mehio A  Khan R  Tan SL  Wischmeijer A  Coullin P  Xie X  Slim R.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/19066229,Exon 6,0.708,1
Q8WX94_Asp722Gly,NLRP7,D722G,p.(Asp722Gly),c.2165A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,568,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole NLRP7-AID-Spontaneous abortions ,China/Asian,--,2008-07-11,Slim  R   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/19066229,Exon 6,0.367,0
Q8WX94_His735Pro,NLRP7,H735P,p.(His735Pro),c.2204A>C,substitution,1,A>C,Uncertain significance (VUS),PROVISIONAL,YES,NO,--,--,--,Sequencing Sanger ,--,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,"Iran, islamic republic of/Asian",--,2019-04-10,Rima Slim   Publication (in_press): New variants in NLRP7 gene in patients with Recurrent Hydatidiform Moles,Exon 6,0.725,1
Q8WX94_Cys761Tyr,NLRP7,C761Y,p.(Cys761Tyr),c.2282G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,390,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole NLRP7-AID-Persistant trophoblastic disease ,China/Asian,--,2009-03-23,Wang  et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/19246479,Exon 6,0.665,1
Q8WX94_Arg815His,NLRP7,R815H,p.(Arg815His),c.2444G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,Algeria/Maghrebian,--,2008-12-28,Slim  R    Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21659348,Exon 7,0.76,1
Q8WX94_Ala833Thr,NLRP7,A833T,p.(Ala833Thr),c.2497G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,UNKNOWN,Senegal/African,--,2009-06-17,Slim  R.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/21948117,Exon 8,0.53,1
Q8WX94_Ile858Thr,NLRP7,I858T,p.(Ile858Thr),c.2573T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Non-recurrent hydatiform mole ,China/Asian,--,2015-10-27,Begemann   Publication (Medline Abstract): https://pubmed.ncbi.nlm.nih.gov/29574422/,Exon 8,0.956,1
Q8WX94_Leu880Ser,NLRP7,L880S,p.(Leu880Ser),c.2639T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole ,Algeria/Maghrebian,--,2008-05-16,Muhlstein J  Golfier F  Rittore C  Hajri T  Philibert L  Abel F  Beneteau C  Touitou I.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/21439709,Exon 8,0.963,1
Q8WX94_Leu964Pro,NLRP7,L964P,p.(Leu964Pro),c.2891T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP7-AID-Recurrent Hydatidiform Mole Blighted ovum,France/Caucasian,--,2008-05-16,Golfier F  Hajri T  Rittore-Domingo C  Touitou I   Personal communication,Exon 10,0.973,1
Q92539_Gly428Ser,LPIN2,G428S,p.(Gly428Ser),c.1282G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,/,--,2019-07-16,Rusmini M  Federici S  Caroli F  Grossi A  Baldi M  Obici L  Insalaco A  Tommasini A  Caorsi R  Gallo E  Olivieri AN  Marzano A  Coviello D  Ravazzolo R  Martini A  Gattorno M  Ceccherini I.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/26386126,Exon 9,0.576,1
Q92539_Ser579Pro,LPIN2,S579P,p.(Ser579Pro),c.1735T>C,substitution,1,T>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 13,0.58,1
Q92539_Pro599Leu,LPIN2,P599L,p.(Pro599Leu),c.1796C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,/,--,2019-07-16,Rusmini M  Federici S  Caroli F  Grossi A  Baldi M  Obici L  Insalaco A  Tommasini A  Caorsi R  Gallo E  Olivieri AN  Marzano A  Coviello D  Ravazzolo R  Martini A  Gattorno M  Ceccherini I.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/26386126,Exon 14,0.175,0
Q92539_Asp644Gly,LPIN2,D644G,p.(Asp644Gly),c.1931A>G,substitution,1,A>G,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,Israel/Ashkenazi Jewish ,also heterozygouse for the p.V726A pathogenic variant of pyrin ,2019-08-26,Igbaria R  Shinar Y    Personal communication,Exon 14,0.085,0
Q92539_Gly823Ala,LPIN2,G823A,p.(Gly823Ala),c.2468G>C,substitution,1,G>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 19,0.58,1
Q92539_Cys874Phe,LPIN2,C874F,p.(Cys874Phe),c.2621G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,Spain/Mediterranean,--,2019-05-13,Desjonqueres  M  Rittore  C  Imbert-Bouteille  M  Sarrabay  G  Touitou  I   Personal communication,Exon 20,0.576,1
Q92542_Val75Ile,NCSTN,V75I,p.(Val75Ile),c.223G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial Acne inversa,China/Asian,--,2019-01-22,Zhang C et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22759192,Exon 3,0.153,0
Q92542_Asp185Asn,NCSTN,D185N,p.(Asp185Asn),c.553G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial Acne inversa,United kingdom/,--,2019-01-22,Pink AE et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22622421,Exon 5,0.485,0
Q92542_Pro211Arg,NCSTN,P211R,p.(Pro211Arg),c.632C>G,substitution,1,C>G,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial Acne inversa,China/Asian,--,2019-01-22,Li CR et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/21495993,Exon 6,0.348,0
Q92542_Gln216Pro,NCSTN,Q216P,p.(Gln216Pro),c.647A>C,substitution,1,A>C,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial Acne inversa,China/Asian,--,2019-01-22,Zhang C et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22759192,Exon 6,0.142,0
Q92542_Glu296Gly,NCSTN,c.887A>G,p.(Glu296Gly),c.887A>G,substitution,1,A>G,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial acne inversa,China/Asian,--,2019-01-24,Xu H et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/26522179,Exon 8,0.339,0
Q92542_Ala315Val,NCSTN,A315V,p.(Ala315Val),c.944C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,UNKNOWN,--,--,--,Sequencing Sanger ,--,Symptomatic ,Familial acne inversa,China/Asian,--,2019-01-24,Zhang S et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/26463457,Exon 8,0.409,0
Q969U7_Asn213Ser,PSMG2,N213S,p.(Asn213Ser),c.638A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Hemophagocytic lymphohistiocytosis,French guiana/Suriname,"lymphadenopathy, hepatosplenomegaly, oedema, anemia. Suspicion of atypical Kawasaki.",2020-05-19,Melki I  Rittore C  Boursier G  Touitou I   Personal communication,Exon 6,0.661,1
Q96P20_His49Arg,NLRP3,H49R,p.(His49Arg),c.146A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,"recurrent episodes of uveitis and neurosensorial hypoacusia that appeared during the adulthood, with no other clinical features of CAPS",/,--,2013-07-01,"E. Gonzalez-Roca  G. Espinosa  J. Bartra  E. Ruiz-Ortiz  J. Rius  S. Plaza  J. Yague  J. I. Arostegui   Congress abstract:Autoinflammation 2013, Lausanne, Switzerland, 22-26 May 2013",Exon 1,0.831,1
Q96P20_Val70Met,NLRP3,V70M,p.(Val70Met),c.208G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,NLRP3-AID (CAPS undefined) ,China/,--,2019-06-09,Wu  D  Shen  M   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28028683,Exon 1,0.887,1
Q96P20_Ala75Val,NLRP3,A75V,p.(Ala75Val),c.224C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,Recurrent Fever ,Italy/Caucasian,--,2017-08-18,Ceccherini I   Personal communication,Exon 1,0.976,1
Q96P20_Asp88Tyr,NLRP3,D88Y,p.(Asp88Tyr),c.262G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Belot  A  Rittore  C  Imbert-Bouteille  M  Sarrabay  G Touitou  I   Personal communication,Exon 1,0.864,1
Q96P20_Arg98Gly,NLRP3,R98G,p.(Arg98Gly),c.292C>G,substitution,1,C>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/Mediterranean,bipolar aphtosis and arthritis,2019-11-08,Rousselin C  Rittore C  Boursier G  Touitou I   Personal communication,Exon 2,0.992,1
Q96P20_Arg98His,NLRP3,R98H,p.(Arg98His),c.293G>A,substitution,1,G>A,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,Undefined-AID ,China/,--,2019-06-09,Li C  Tan X  Zhang J  Li S  Mo W  Han T  Kuang W  Zhou Y  Deng J.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/29285715,Exon 2,0.989,1
Q96P20_Cys148Tyr,NLRP3,C148Y,p.(Cys148Tyr),c.443G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,40,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-severe (CINCA/NOMID) ,Brazil/,--,2007-12-24,Jesus et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/18080732,Exon 3,0.978,1
Q96P20_Lys173Glu,NLRP3,K173E,p.(Lys173Glu),c.517A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,Atypical CAPS,Brazil/,--,2013-02-05,Jesus AA et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22566169,Exon 3,0.979,1
Q96P20_Thr193Lys,NLRP3,T193K,p.(Thr193Lys),c.578C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Recurrent Fever ,United states/Cherokee Indian/caucasian,--,2011-01-04,Aksentijevich  I   Personal communication,Exon 3,0.93,1
Q96P20_Thr193Met,NLRP3,T195M,p.(Thr193Met),c.578C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,T195M mutant NLRP3/cryopyrin-transfected cells have a slight but significant decrease in the number of specks in comparison with WT NLRP3/cryopyrin-transfected cells. ;These data suggest that the T195M mutant NLRP3/cryopyrin protein does not have a pronounced positive effect on ASC oligomerization.  ,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,Behçet's disease ,Turkey/,The name has been edited as compared to the publication to comply with this nomenclature.,2014-11-03,Yuksel S et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/24135410,Exon 3,0.99,1
Q96P20_Val198Met,NLRP3,V198M,p.(Val198Met),c.592G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,178,Sequencing Sanger ,creates NlaIII catg/,Symptomatic ,NLRP3-AID-mild (FCAS) NLRP3-AID-moderate (MWS) Recurrent Fever ,United kingdom/,Low penetrance mutation,2002-07-12,Aganna E et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12355493,Exon 3,0.853,1
Q96P20_Asp211Asn,NLRP3,D211N ,p.(Asp211Asn),c.631G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-mild (FCAS) ,Italy/Caucasian,--,2013-08-30,Gattorno M Ceccherini I   Personal communication,Exon 3,0.969,1
Q96P20_His213Arg,NLRP3,H213R,p.(His213Arg),c.638A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,400,Sequencing Sanger ,NO,Symptomatic ,Cryopyrin-associated periodic syndromes,Spain/Caucasian,--,2014-02-21,Soler-Palacin P  Ruiz-Ortiz E  Gonzalez-Roca  E  Yague J  Arostegui  Juan I   Personal communication,Exon 3,0.847,1
Q96P20_Ala225Val,NLRP3,A225V,p.(Ala225Val),c.674C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,"Rheumatoid Arthritis With CCP-antibodies, high leukocyte count and recurrent fever.",Sweden/,--,2008-04-23,"Verma D  Eriksson P  Särndahl E  Söderkvist P   Congress abstract:fmfsaid2008, Rome, Italy, 080405",Exon 3,0.831,1
Q96P20_Asp280Asn,NLRP3,D280N,p.(Asp280Asn),c.838G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Unknown,UNKNOWN,/,--,2014-04-01,Sarrabay G Mechin D Touitou I   Personal communication,Exon 3,0.898,1
Q96P20_Ile288Met,NLRP3,I288M,p.(Ile288Met),c.864C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Substitution  ,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Atypical inflammatory disease,Italy/Caucasian,The mutation is likely not pathogenic. ,2013-05-21,Salsano  E et al.   Publication (Medline Abstract): http://www.jneuroinflammation.com/content/pdf/1742-2094-10-29.pdf,Exon 3,0.99,1
Q96P20_Met299Val,NLRP3,M299V,p.(Met299Val),c.895A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever Rheumatoid Arthritis Muscle pain,Sweden/,--,2008-04-23,"Verma D Eriksson P Särndahl E Söderkvist P   Congress abstract:fmfsaid2008, Rome, Italy, 080405",Exon 3,0.929,1
Q96P20_Ile313Val,NLRP3,I313V,p.(Ile313Val),c.937A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,50,DGGE Sequencing Sanger ,creates MaeII a/cgt,Symptomatic ,Magic syndrome ,France/Caucasian,--,2009-03-09,Kaplanski G Dumont B Touitou I   Personal communication,Exon 3,0.998,1
Q96P20_Pro315Leu,NLRP3,P315L,p.(Pro315Leu),c.944C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-severe (CINCA/NOMID) ,India/,--,2006-01-23,Bybee A  Agannna  E  Lachmann  HJ  Nedjal  B  McDermott MF  Hawkins  PN   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/26218404?dopt=Abstract,Exon 3,0.994,1
Q96P20_Arg325Gln,NLRP3,R325Q,p.(Arg325Gln),c.974G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,UNKNOWN,United states/Caucasian,--,2010-05-06,Aksentijevich I   Personal communication,Exon 3,0.875,1
Q96P20_Ser332Asn,NLRP3,S332N,p.(Ser332Asn),c.995G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,>999,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Unclassified autoinflammatory syndrome ,Netherlands/Caucasian,--,2017-08-18,M.E. van Gijn   Personal communication,Exon 3,0.987,1
Q96P20_Leu369Met,NLRP3,L369M,p.(Leu369Met),c.1105C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Atypical CAPS,Italy/Caucasian,--,2012-09-03,"Insalaco A. Buonuomo PS  Ceccherini I.  Bracaglia C  Pardeo M.  Nicolai R.  de Benedetti F.   Congress abstract:EULAR, Berlin, Germany, 2012",Exon 3,0.984,1
Q96P20_Lys375Glu,NLRP3,K375E,p.(Lys375Glu),c.1123A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,missense mutation  ,--,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,NLRP3-AID-mild (FCAS) ,Caucasian/,--,2011-08-03,Canoui E  Maigne G  Jeru I  Amselem S  Kone-Paut I  Lambotte O.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/23811320,Exon 3,0.914,1
Q96P20_Glu378Lys,NLRP3,E378K,p.(Glu378Lys),c.1132G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,Juvenile Idiopathic Arthritis ,Japan/Asian,--,2012-01-12,Ohnishi H et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22193915,Exon 3,0.992,1
Q96P20_Met406Thr,NLRP3,M406T,p.(Met406Thr),c.1217T>C,substitution,1,T>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,NLRP3-AID-severe (CINCA/NOMID) ,Ukraine/Caucasian,--,2020-01-28,"Stepanovskyy  Y.   Congress abstract:3rd J-PROJECT Congress in Konya, Turkey, December 4-7, 2019",Exon 3,0.922,1
Q96P20_Lys435Glu,NLRP3,K435E,p.(Lys435Glu),c.1303A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Schnitzler's syndrome ,/,--,2013-07-01,H. D. De Koning  J. Schalkwijk  J. W. van der Meer  P. L. Zeeuwen  K. Neveling  M. van Gijn  A. Simon   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/25239704,Exon 3,0.807,1
Q96P20_Tyr441His,NLRP3,Y441H,p.(Tyr441His),c.1321T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,aminoacid change  ,--,Sequencing Sanger ,creates ApaLI g/tgcac,Symptomatic ,NLRP3-AID-moderate (MWS) Muckle-Wells and NOMID/CINCA overlap,Turkey/Caucasian,--,2008-12-02,Gul  A   Personal communication,Exon 3,0.994,1
Q96P20_Arg488Lys,NLRP3,R488K,p.(Arg488Lys),c.1463G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,300,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-mild (FCAS) ,Spain/,--,2003-01-13,Aldea  A  Arostegui  JI  Gonzalez-Enseñat  MA  Yagüe  J   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15593220,Exon 3,0.978,1
Q96P20_Ala495Val,NLRP3,A495V,p.(Ala495Val),c.1484C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,400,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-moderate (MWS) ,Portugal/Caucasian,--,2007-03-15,Arostegui JI  Figueiredo A  Yague J   Personal communication,Exon 3,0.98,1
Q96P20_Met521Thr,NLRP3,M521T,p.(Met521Thr),c.1562T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,50,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-moderate (MWS) ,/,--,2013-07-02,Van Maldergem L  Dumont B  Barat-Houari M  Touitou I   Personal communication,Exon 3,0.988,1
Q96P20_Thr542Met,NLRP3,T544M,p.(Thr542Met),c.1625C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Unknown ,UNKNOWN,Symptomatic ,CAPS ,/Caucasian,The name has been changed at the protein level as compared to the initial publication to match the current nomenclature,2014-12-03,Berman N et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/25417688,Exon 3,0.955,1
Q96P20_Thr557Ala,NLRP3,T557A,p.(Thr557Ala),c.1669A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,220,Sequencing Sanger ,UNKNOWN,Symptomatic ,Recurrent Fever ,Spain/,--,2006-01-11,Cid MC  Arostegui JI  Yague J   Personal communication,Exon 3,0.933,1
Q96P20_Lys565Glu,NLRP3,K565E,p.(Lys565Glu),c.1693A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,NLRP3-AID (CAPS undefined) ,France/,--,2019-12-19,Merlin E  Rittore C  Boursier G  Touitou I   Personal communication,Exon 3,0.972,1
Q96P20_Asp646Tyr,NLRP3,D646Y,p.(Asp646Tyr),c.1936G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,400,Sequencing Sanger ,NO,Symptomatic ,Clinical suspicion of cryopyrin-associated periodic syndromes (CAPS),Spain/Caucasian,--,2014-02-24,Baucells JM  Ruiz-Ortiz E  Gonzalez-Roca  E  Yague J  Arostegui  Juan I   Personal communication,Exon 3,0.831,1
Q96P20_Leu677Pro,NLRP3,L677P,p.(Leu677Pro),c.2030T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,CAPS ,Netherlands/Netherlands,--,2013-05-06,Marielle Van Gijn   Personal communication,Exon 3,0.726,1
Q96P20_Met701Thr,NLRP3,M701T,p.(Met701Thr),c.2102T>C,substitution,1,T>C,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,50,Sequencing Sanger HRM ,NO,Symptomatic ,NLRP3-AID-moderate (MWS) ,France/Jewish Non Ashkenasi,--,2008-08-18,Longy Boursier  M  Dumont  B  Touitou  I   Personal communication,Exon 3,1.0,1
Q96P20_Gln703Lys,NLRP3,Q703K,p.(Gln703Lys),c.2107C>A,substitution,1,C>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Non symptomatic ,UNKNOWN,Spain/,"The prevalence of this variant in the general population ranges from 5-11% (Aksentijevich, Cuisset, Yague, personal communication)",2002-12-12,Aldea A  Arostegui JI  Campistol JM  Yagüe J   Personal communication,Exon 3,0.986,1
Q96P20_Ser710Cys,NLRP3,S710C,p.(Ser710Cys),c.2129C>G,substitution,1,C>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,200,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-moderate (MWS) ,Spain/,--,2004-11-15,Arostegui JI  Anton J  Bou R  Franco W  Yague J   Personal communication,Exon 3,0.965,1
Q96P20_Ala712Ser,NLRP3,A712S,p.(Ala712Ser),c.2134G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,urticarial rash without inflammation (sample from  our allergologists),Italy/Caucasian,--,2013-08-16,Gattorno M  Ceccherini I   Personal communication,Exon 3,0.995,1
Q96P20_Ser726Gly,NLRP3,S726G,p.(Ser726Gly),c.2176A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-severe (CINCA/NOMID) ,Turkey/Caucasian,--,2011-07-14,Berdeli A  Pasholar A  Tigli D  Atan M  Demirel I  Toparlak P  Nalbantoglu S.   Congress abstract:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952441/,Exon 4,0.95,1
Q96P20_Arg777Cys,NLRP3,R777C,p.(Arg777Cys),c.2329C>T,substitution,1,C>T,Uncertain significance (VUS),--,NO,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,Undefined-AID ,China/,--,2019-06-09,Li C  Tan X  Zhang J  Li S  Mo W  Han T  Kuang W  Zhou Y  Deng J.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/29285715,Exon 5,0.974,1
Q96P20_Asp787Asn,NLRP3,D787N,p.(Asp787Asn),c.2359G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Quartier  P  Rittore  C  Tharreau  M  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.987,1
Q96P20_Gly807Ser,NLRP3,G809S,p.(Gly807Ser),c.2419G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,100,Sequencing Sanger ,UNKNOWN,Symptomatic ,NLRP3-AID-severe (CINCA/NOMID) ,Japan/Asian,--,2012-01-12,Ohnishi H et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22193915,Exon 5,0.923,1
Q96P20_Gly866Arg,NLRP3,G866R,p.(Gly866Arg),c.2596G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,500,Sequencing Sanger ,UNKNOWN,Symptomatic ,CAPS ,Morocco/Morocco,--,2013-05-06,Marielle Van Gijn   Personal communication,Exon 6,0.907,1
Q96P20_Ser896Pro,NLRP3,S896P,p.(Ser896Pro),c.2686T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,UNKNOWN,Symptomatic ,Recurrent Fever ,/Caucasian/Maghrebian,--,2017-09-05,Belot A  Sarrabay G  Rittore C  Touitou I   Personal communication,Exon 7,0.996,1
Q96P20_Thr952Met,NLRP3,T952M,p.(Thr952Met),c.2855C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,"pharmacological allergy, and skin rash in hands, arms and auricular pavilions that apparently appeared in winter and after cold exposure",/,--,2013-07-01,"E. Gonzalez-Roca  G. Espinosa  J. Bartra  E. Ruiz-Ortiz  J. Rius  S. Plaza  J. Yague  J. I. Arostegui   Congress abstract:Autoinflammation 2013, Lausanne, Switzerland, 22-26 May 2013",Exon 8,0.856,1
Q96P20_Met986Ile,NLRP3,M986I,p.(Met986Ile),c.2958G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Merlin  E  Rittore  C  Imbert-Bouteille  M  Sarrabay  G Touitou  I   Personal communication,Exon 8,0.955,1
Q96PC3_Ile31Thr,AP1S3,I31T,p.(Ile31Thr),c.92T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Caucasian,--,2019-05-13,Jarrin I Rittore C Rama M Sarrabay G Touitou I   Personal communication,Exon 2,0.869,1
Q96PC3_Thr32Ile,AP1S3,T32I,p.(Thr32Ile),c.95C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,/Latino,Seen in homozygosity in this patient,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 2,0.535,1
Q96PC3_Arg33Gln,AP1S3,R33Q,p.(Arg33Gln),c.98G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,United kingdom/England/Italy,--,2019-11-08,Touitou I   Personal communication,Exon 2,0.435,0
Q96PC3_Leu79Val,AP1S3,L79V,p.(Leu79Val),c.235T>G,substitution,1,T>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,PAAD-FMF (with criteria) ,Algeria/Mediterranean,--,2019-05-13,Kone-Paut I Rittore C Imbert-Bouteille M Sarrabay G Touitou I   Personal communication,Exon 3,0.793,1
Q96PC3_Ile83Thr,AP1S3,I83T,p.(Ile83Thr),c.248T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Caucasian,--,2019-05-13,Richer O Rittore C Imbert-Bouteille M Sarrabay G Touitou I   Personal communication,Exon 3,0.772,1
Q96Q11_Thr154Ile,TRNT1,T154L,p.(Thr154Ile),c.461C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,YES,Culture studies  ,Effect on enzymatic activity  ,--,Sequencing NGS ,--,Symptomatic ,"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)",Canada/Caucasian,Milder phenotype,2019-01-21,Chakraborty et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/25193871,Exon 4,0.425,0
Q96Q11_Ile326Thr,TRNT1,I326T,p.(Ile326Thr),c.977T>C,substitution,1,T>C,Uncertain significance (VUS),--,YES,YES,Culture studies  ,Effect on enzymatic activity  ,--,Sequencing NGS ,--,Symptomatic ,"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)",Canada/Caucasian,Milder phenotype,2019-01-21,Chakraborty et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/25193871,Exon 7,0.418,0
Q9BXL6_Met119Lys,CARD14,M119K,p.(Met119Lys),c.356T>A,substitution,1,T>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Generalized pustular psoriasis,France/Mediterranean,--,2021-01-19,Phan A  Rittore C  Sarrabay G  Boursier G  Touitou I   Personal communication,Exon 4,0.386,0
Q9BXL6_Ala254Thr,CARD14,A254T,p.(Ala254Thr),c.760G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,France/,Suspected PAPA/PASH syndrome or Verneuil disease but no mutations identified in PSTPIP1 or NSCTN,2020-07-07,Tieulé N  Rittore C  Boursier G  Touitou I   Personal communication,Exon 5,0.484,0
Q9BXL6_Arg266Cys,CARD14,R266C,p.(Arg266Cys),c.796C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Reccurent fever,France/Caucasian,--,2019-05-13,Bachelez H Rittore C Rama M Sarrabay G Touitou I   Personal communication,Exon 5,0.498,0
Q9BXL6_Arg311Trp,CARD14,R311W,p.(Arg311Trp),c.931C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,UNKNOWN,/,--,2019-05-13,Duffau P Rittore C Ruault V Boursier G Touitou I   Personal communication,Exon 6,0.478,0
Q9BXL6_Arg319Gln,CARD14,R319Q,p.(Arg319Gln),c.956G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,/,--,2021-01-11,Bozgeyik A et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/32199921,Exon 6,0.395,0
Q9BXL6_Val354Met,CARD14,V354M,p.(Val354Met),c.1060G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Recurrent fever,France/Caucasian,--,2019-05-13,Hentgen V Rittore C Sarrabay G Touitou I   Personal communication,Exon 7,0.394,0
Q9BXL6_Ala512Thr,CARD14,A512T,p.(Ala512Thr),c.1534G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 11,0.362,0
Q9BXL6_Pro600Leu,CARD14,P600L,p.(Pro600Leu),c.1799C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,Senegal/African,--,2019-05-13,Cherquaoui B Rittore C Ruault V Boursier G Touitou I   Personal communication,Exon 13,0.473,0
Q9BXL6_Arg610His,CARD14,R610H,p.(Arg610His),c.1829G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 13,0.326,0
Q9BXL6_Leu847Phe,CARD14,L847F,p.(Leu847Phe),c.2539C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Caucasian,--,2019-05-13,Gril Tamani S Rittore C Rama M Sarrabay G Touitou I   Personal communication,Exon 18,0.309,0
Q9BYM8_Asn122His,RBCK1,N122H,p.(Asn122His),c.364A>C,substitution,1,A>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 4,0.311,0
Q9BYM8_Val295Leu,RBCK1,V295L,p.(Val295Leu),c.883G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Richer  O  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 7,0.721,1
Q9BYM8_Cys305Phe,RBCK1,C305F,p.(Cys305Phe),c.914G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Caucasian,--,2019-05-13,Castros  F  Rittore  C  Boursier  G  Sarrabay  G  Touitou  I   Personal communication,Exon 7,0.602,1
Q9BYM8_Ala319Val,RBCK1,A319V,p.(Ala319Val),c.956C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/Mediterranean,--,2019-05-13,Galeotti  C  Rittore  C  Fabre  A  Sarrabay  G  Touitou  I   Personal communication,Exon 8,0.426,0
Q9HC29_Arg38Met,NOD2,R38M,p.(Arg38Met),c.113G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,380,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic ,Crohn's disease CD with short bowel syndrome,Finland/Caucasian,This patient is also homozygous for the 1007fs mutation.  The sequence and/or protein name of this variant has been edited as compared to that in the initial publication,2007-10-29,Lappalainen  M et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/17941079,Exon 2,0.915,1
Q9HC29_Leu81Val,NOD2,L81V,p.(Leu81Val),c.241C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2016-10-13,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano and María Francisca González-Escribano et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 2,0.582,1
Q9HC29_Leu155Gln,NOD2,L155Q,p.(Leu155Gln),c.464T>A,substitution,1,T>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Arthritis,France/Mediterranean,p.Thr189Met known in Hugot et al. (PMID:11385576),2019-05-13,Lefevre-Utile  A  Rittore  C  Ruault  V  Bouriser  G  Sarrabay  G  Touitou  I   Personal communication,Exon 2,0.986,1
Q9HC29_Thr189Met,NOD2,T189M,p.(Thr189Met),c.566C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,206,Sequencing Sanger dHPLC ,creates NcoI c/catgg,Unknown,Rheumatoid Arthritis Spondylarthropathy Ulcerative Colitis ,Sweden/,--,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 3,0.536,1
Q9HC29_Phe198Leu,NOD2,F198L,p.(Phe198Leu),c.594C>G,substitution,1,C>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID Absence of granulomatosis,France/,--,2019-05-13,Cheyssac  E  Rittore  C  Bouriser  G  Touitou  I   Personal communication,Exon 3,0.868,1
Q9HC29_Arg235Cys,NOD2,R235C,p.(Arg235Cys),c.703C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,destroys BseMII ctcag,Unknown,Crohn's disease ,/Caucasian,Diminution of the PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.605,1
Q9HC29_Thr245Met,NOD2,T245M,p.(Thr245Met),c.734C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,384,Sequencing Sanger ,UNKNOWN,Symptomatic Non symptomatic ,Crohn's disease ,Japan/Asian,--,2011-09-02,Sugimura M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12630966,Exon 4,0.645,1
Q9HC29_Leu248Arg,NOD2,L248R,p.(Leu248Arg),c.743T>G,substitution,1,T>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,206,Sequencing Sanger ,destroys BpmI ctggag,Unknown,Crohn's disease ,/Caucasian,--,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.612,1
Q9HC29_His287Tyr,NOD2,H287Y,p.(His287Tyr),c.859C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,NOD2-associated granulomatous disease (Blau) ,Tunisia/,--,2015-12-23,Galeotti C Dumont B Sarrabay G Touitou I   Personal communication,Exon 4,0.817,1
Q9HC29_Asp291Asn,NOD2,D291N,p.(Asp291Asn),c.871G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,destroys SfaNI gcatc,Unknown,Crohn's disease ,/Caucasian,Diminution of both basal and PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.743,1
Q9HC29_Ala301Val,NOD2,A301V,p.(Ala301Val),c.902C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,206,Sequencing Sanger ,UNKNOWN,Unknown,Crohn's disease ,/Caucasian,--,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.813,1
Q9HC29_Leu349Phe,NOD2,L349F,p.(Leu349Phe),c.1045C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2016-11-07,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano  María Francisca González-Escribano  et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 4,0.567,1
Q9HC29_Asp357Ala,NOD2,D357A,p.(Asp357Ala),c.1070A>C,substitution,1,A>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,376,Sequencing Sanger dHPLC ,NO,Unknown,Crohn's disease ,United states/Jewish Ashkenasi,--,2004-08-05,Tukel T  Shalat A  Present D  Rachmilewitz D  Mayer L  Grant D  Risch N  Desnick RJ   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15024686,Exon 4,0.842,1
Q9HC29_Arg391Cys,NOD2,R391C,p.(Arg391Cys),c.1171C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Indeterminate colitis ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.696,1
Q9HC29_Arg393His,NOD2,R393H,p.(Arg393His),c.1178G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,1328,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic ,Crohn's disease ,United kingdom/,--,2011-09-02,King K   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16278823,Exon 4,0.978,1
Q9HC29_Pro397Leu,NOD2,P397L,p.(Pro397Leu),c.1190C>T,substitution,1,C>T,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing NGS ,--,Symptomatic ,UNKNOWN,/,--,2019-07-16,Rusmini M  Federici S  Caroli F  Grossi A  Baldi M  Obici L  Insalaco A  Tommasini A  Caorsi R  Gallo E  Olivieri AN  Marzano A  Coviello D  Ravazzolo R  Martini A  Gattorno M  Ceccherini I.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/26386126,Exon 4,0.7,1
Q9HC29_Asn414Ser,NOD2,N414S,p.(Asn414Ser),c.1241A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,destroys BspMI acctgc,Unknown,Crohn's disease Spondylarthropathy ,/Caucasian,Non alteration of the NF-kB response,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.672,1
Q9HC29_Pro427Ser,NOD2,P427S,p.(Pro427Ser),c.1279C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Pajot  C  Rittore  C  Tharreau  M  Boursier  G  Sarrabay  G Touitou  I   Personal communication,Exon 4,0.618,1
Q9HC29_Glu441Lys,NOD2,E441K,p.(Glu441Lys),c.1321G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,NO,Unknown,Crohn's disease ,Spain/,Diminution of the PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.652,1
Q9HC29_Pro463Ala,NOD2,P463A,p.(Pro463Ala),c.1387C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Ulcerative Colitis ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.402,0
Q9HC29_Thr510Ile,NOD2,T510I,p.(Thr510Ile),c.1529C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Cherquaoui  B  Rittore  C  Sarrabay  G Touitou  I   Personal communication,Exon 4,0.582,1
Q9HC29_Leu550Val,NOD2,L550V,p.(Leu550Val),c.1648C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,164,Sequencing Sanger Dot blot ,NO,Symptomatic ,UNKNOWN,United states/Jewish Non Ashkenasi,--,2004-08-05,Tukel T  Shalata A  Present D  Rachmilewitz D  Mayer L  Grant D  Risch N  Desnick RJ   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15024686,Exon 4,0.924,1
Q9HC29_Ala612Thr,NOD2,A612T,p.(Ala612Thr),c.1834G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,creates MaeII a/cgt,Unknown,Crohn's disease Rheumatoid Arthritis ,France/,Diminution of both basal and PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.941,1
Q9HC29_Ala612Val,NOD2,A612V,p.(Ala612Val),c.1835C>T,substitution,1,C>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,UNKNOWN,Unknown,Crohn's disease ,/Caucasian,Diminution of both basal and PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.889,1
Q9HC29_Pro668Leu,NOD2,P668L,p.(Pro668Leu),c.2003C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,NOD2-associated granulomatous disease (Blau) ,France/,--,2015-12-23,Galeotti C Dumont B Sarrabay G Touitou I   Personal communication,Exon 4,0.847,1
Q9HC29_Leu682Phe,NOD2,L682F,p.(Leu682Phe),c.2046G>T,substitution,1,G>T,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,1000,Sequencing Sanger ,UNKNOWN,Symptomatic ,NOD2-associated granulomatous disease (Blau) ,Tunisia/,--,2015-12-23,Galeotti C Dumont B Sarrabay G Touitou I   Personal communication,Exon 4,0.763,1
Q9HC29_Arg684Gln,NOD2,R684Q,p.(Arg684Gln),c.2051G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,NO,Symptomatic ,Sarcoidosis,Caribbean/,--,2013-07-03,Kambouris  M  El-Shanti H   Personal communication,Exon 4,0.339,0
Q9HC29_Arg713Cys,NOD2,R713C,p.(Arg713Cys),c.2137C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,UNKNOWN,Unknown,Crohn's disease ,/Caucasian,Diminution of the PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.712,1
Q9HC29_Arg713His,NOD2,R713H,p.(Arg713His),c.2138G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.722,1
Q9HC29_Pro727Leu,NOD2,P727L,p.(Pro727Leu),c.2180C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,380,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic ,Crohn's disease ,Finland/Caucasian,--,2007-10-29,Lappalainen M et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/17941079,Exon 4,0.891,1
Q9HC29_Val733Leu,NOD2,V733L,p.(Val733Leu),c.2197G>T,substitution,1,G>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2016-10-13,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano and María Francisca González-Escribano et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 4,0.807,1
Q9HC29_Ala758Val,NOD2,A758V,p.(Ala758Val),c.2273C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,206,Sequencing Sanger ,UNKNOWN,Unknown,Crohn's disease ,Belgium/,--,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.592,1
Q9HC29_Arg760Cys,NOD2,R760C,p.(Arg760Cys),c.2278C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.901,1
Q9HC29_Glu778Lys,NOD2,E778K,p.(Glu778Lys),c.2332G>A,substitution,1,G>A,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger ,UNKNOWN,Unknown,Crohn's disease ,Sweden/,Diminution of the PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 4,0.687,1
Q9HC29_Arg790Trp,NOD2,R790W,p.(Arg790Trp),c.2368C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,/,--,2006-05-10,Schnitzler  F   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.492,0
Q9HC29_Arg791Trp,NOD2,R791W,p.(Arg791Trp),c.2371C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Indeterminate colitis ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 4,0.381,0
Q9HC29_Val816Ile,NOD2,V816I,p.(Val816Ile),c.2446G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2016-10-27,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano  María Francisca González-Escribano  et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 4,0.652,1
Q9HC29_Asn825Lys,NOD2,N825K,p.(Asn825Lys),c.2475C>G,substitution,1,C>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 5,0.347,0
Q9HC29_Ile836Thr,NOD2,I836T,p.(Ile836Thr),c.2507T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID HLH,France/Mediterranean,--,2019-05-13,Rossi  L  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.606,1
Q9HC29_Glu843Lys,NOD2,E843K,p.(Glu843Lys),c.2527G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,206,Sequencing Sanger dHPLC ,creates Tth111II caarca,Unknown,Crohn's disease ,France/,Diminution of the PGN-induced potential of NF-kB activation,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 5,0.82,1
Q9HC29_Ala849Val,NOD2,A849V,p.(Ala849Val),c.2546C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger ,UNKNOWN,Symptomatic ,Crohn's disease ,/,--,2006-05-10,Schnitzler  F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16485124,Exon 5,0.816,1
Q9HC29_Asn852Ser,NOD2,N852S,p.(Asn852Ser),c.2555A>G,substitution,1,A>G,Uncertain significance (VUS),PROVISIONAL,UNKNOWN,NO,--,--,492,RFLP Sequencing Sanger ,NO,Unknown,Crohn's disease  ,United states/Jewish Ashkenasi,The frequency in familial Ashkenazi Jewish Crohn's patients (0.035) was increased compared to healthy Ashkenazi Jewish controls (0.012). ,2004-08-05,Tukel T  Shalata A  Present D  Rachmilewitz D  Mayer L  Grant D  Risch N  Desnick RJ   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15024686,Exon 6,0.695,1
Q9HC29_Asn853Ser,NOD2,N853S,p.(Asn853Ser),c.2558A>G,substitution,1,A>G,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,206,Sequencing Sanger ,NO,Unknown,Crohn's disease ,Belgium/,--,2003-05-13,Hugot  JP et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 6,0.669,1
Q9HC29_Ala864Thr,NOD2,A864T,p.(Ala864Thr),c.2590G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,UNKNOWN,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 6,0.767,1
Q9HC29_Trp907Arg,NOD2,W907R,p.(Trp907Arg),c.2719T>C,substitution,1,T>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,380,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic ,Crohn's disease CD with short bowel syndrome,Finland/Caucasian,Patient is also heterozygous for the T294S variant,2007-10-29,Lappalainen M et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/17941079,Exon 8,0.618,1
Q9HC29_Gly908Arg,NOD2,G908R/SNP12,p.(Gly908Arg),c.2722G>C,substitution,1,G>C,Uncertain significance (VUS),VALIDATED,UNKNOWN,YES,Unknown  ,Unknown  ,174,RFLP Sequencing Sanger ,creates HhaI gcg/c,Unknown,Crohn's disease Psoriatic Arthritis Spondylarthropathy Ulcerative Colitis ,/Caucasian,Diminution of both basal and PGN-induced potential of NF-kB activation,2003-06-04,Hugot  JP  et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11385576,Exon 8,0.754,1
Q9HC29_Glu914Lys,NOD2,E914K,p.(Glu914Lys),c.2740G>A,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,NO,--,--,50,Sequencing Sanger ,UNKNOWN,Symptomatic ,NOD2-associated granulomatous disease (Blau) ,/,--,2013-08-27,Tellier S  Dumont B  Barat Houari M  Touitou I   Personal communication,Exon 8,0.805,1
Q9HC29_Arg1019Gly,NOD2,R1019G,p.(Arg1019Gly),c.3055C>G,substitution,1,G>A,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,1054,Sequencing Sanger dHPLC ,UNKNOWN,Symptomatic ,Crohn's disease ,United kingdom/,--,2011-09-02,King K   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16278823,Exon 12,0.631,1
Q9HC29_Arg1019Leu,NOD2,R1019L,p.(Arg1019Leu),c.3056G>T,substitution,1,G>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Carrier  P  Rittore  C  Rama  M  Sarrabay  G  Touitou  I   Personal communication,Exon 12,0.874,1
Q9NPP4_Ile124Thr,NLRC4,I124T,p.(Ile124Thr),c.371T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Amyloidosis and neutrophilic dermatosis,France/Caucasian,--,2020-05-20,Savey L  Rittore C  Boursier G  Touitou I   Personal communication,Exon 4,0.56,1
Q9NPP4_Gly291Ser,NLRC4,G291S,p.(Gly291Ser),c.871G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Undefined-AID ,France/Caucasian,--,2019-05-13,Merlin  E  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 4,0.453,0
Q9NPP4_Ile387Thr,NLRC4,I387T,p.(Ile387Thr),c.1160T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,Algeria/Mediterranean,"recurrent genital and oral aphtosis, arthritis, uveitis",2020-08-25,Georgin-Lavialle S  Rittore C  Boursier G  Touitou I   Personal communication,Exon 4,0.112,0
Q9NPP4_Pro752Leu,NLRC4,P752L,p.(Pro752Leu),c.2255C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,/,--,2019-05-13,Garraffo A  Rittore  C  Tharreau  M  Sarrabay  G  Touitou  I   Personal communication,Exon 4,0.383,0
Q9NUS9_Val4Asp,SLC29A3,V4D,p.(Val4Asp),c.11T>A,substitution,1,T>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,PAPA ,France/,--,2019-05-13,Uthurriague C Rittore C Rama M Bouriser G Sarrabay G Touitou I   Personal communication,Exon 2,0.83,1
Q9NUS9_Asp225Gly,SLC29A3,D225G,p.(Asp225Gly),c.674A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Bessis D Rittore C Rama M Bouriser G Sarrabay G Touitou I   Personal communication,Exon 5,0.725,1
Q9NUS9_Thr236Met,SLC29A3,T236M,p.(Thr236Met),c.707C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Gay C Rittore C Imbert-Bouteille M Bouriser G Sarrabay G Touitou I   Personal communication,Exon 5,0.835,1
Q9NZK5_Ile30Thr,ADA2,I30T,p.(Ile30Thr),c.89T>C,substitution,1,T>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Symptomatic ,Undefined-AID ,India/Asian,Uveitis and deafness  (heterozygous),2021-01-19,Borocco C  Rittore C  Sarrabay G  Boursier G  Touitou I   Personal communication,Exon 2,0.162,0
Q9NZK5_Arg45Trp,ADA2,R45W,p.(Arg45Trp),c.133C>T,substitution,1,C>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,/,--,2019-05-21,Rheumaux H:Rittore C Ruault V Boursier G Touitou I   Personal communication,Exon 2,0.05,0
Q9NZK5_Arg49Trp,ADA2,R49W,p.(Arg49Trp),c.145C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease CAPS,Spain/Caucasian,Also seen in a patient with CAPS like (personnal communication E Rozenberg 11/9/17),2017-01-15,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano and María Francisca González-Escribano   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 2,0.506,1
Q9NZK5_Leu183Pro,ADA2,L183P,p.(Leu183Pro),c.548T>C,substitution,1,T>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,DADA2 ,/,Seen in homozygosity in this patient; patient adopted,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 4,0.437,0
Q9NZK5_Ala247Val,ADA2,A247V,p.(Ala247Val),c.740C>T,substitution,1,C>T,Uncertain significance (VUS),VALIDATED,UNKNOWN,UNKNOWN,--,--,--,Sequencing Sanger Sequencing NGS ,UNKNOWN,Symptomatic ,Behçet's disease ,Spain/Caucasian,--,2017-01-15,Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano and María Francisca González-Escribano   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775,Exon 4,0.235,0
Q9NZK5_Ser479Pro,ADA2,S479P,p.(Ser479Pro),c.1435T>C,substitution,1,T>C,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger Sequencing NGS ,--,Symptomatic ,DADA2 ,Italy/Caucasian,--,2019-07-16,Grossi A  Ceccherini I   Personal communication,Exon 9,0.388,0
Q9NZK5_Glu489Gln,ADA2,E489Q,p.(Glu489Gln),c.1465G>C,substitution,1,G>C,Uncertain significance (VUS),--,UNKNOWN,UNKNOWN,--,--,--,Sequencing NGS ,--,Non symptomatic ,NO,France/,--,2020-05-22,Merlin E  Rittore C  Boursier G  Touitou I   Personal communication,Exon 10,0.163,0
Q9UBH0_Arg103Gln,IL36RN,R103Q,p.(Arg103Gln),c.308G>A,substitution,1,G>A,Uncertain significance (VUS),--,YES,NO,--,--,--,Sequencing Sanger ,--,Symptomatic ,DITRA ,Germany/,--,--,--,Exon 5,0.826,1
Q9UBH0_Ile146Val,IL36RN,I146V,p.(Ile146Val),c.436A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,PAAD-FMF (with criteria) ,France/,MEFV (NM_000243): c.2082G>A p.Met694Ile,2019-05-13,Caillo  L  Rittore  C  Sarrabay  G  Touitou  I   Personal communication,Exon 5,0.793,1
Q9Y6Q6_Gln25Leu,TNFRSF11A,Q25L,p.(Gln25Leu),c.74A>T,substitution,1,A>T,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,NO,France/,--,2019-05-13,Geneviève D Fabre A Barat M Touitou I   Personal communication,Exon 1,0.433,0
Q9Y6Q6_Lys240Glu,TNFRSF11A,K240E,p.(Lys240Glu),c.718A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Non symptomatic ,Undefined-AID Kartagener,Italy/Mediterranean,--,2019-05-13,Soler C Rittore C Rama M Sarrabay G Touitou I   Personal communication,Exon 7,0.145,0
Q9Y6Q6_Gly316Asp,TNFRSF11A,G316D,p.(Gly316Asp),c.947G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,Tunisia/Mediterranean,--,2019-05-13,Melki I Rittore C Sarrabay G Touitou I   Personal communication,Exon 9,0.67,1
Q9Y6Q6_Phe542Leu,TNFRSF11A,F542L,p.(Phe542Leu),c.1626C>A,substitution,1,C>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID DiGeorge,France/,--,2019-05-13,Chevallier B Rittore C Rama M Sarrabay G Touitou I   Personal communication,Exon 10,0.415,0
Q9Y6Q6_Arg568His,TNFRSF11A,R568H,p.(Arg568His),c.1703G>A,substitution,1,G>A,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Symptomatic Non symptomatic ,Undefined-AID ,France/Caucasian,--,2019-05-13,Isidor B Colin E Rittore C Sarrabay G Touitou I   Personal communication,Exon 10,0.677,1
Q9Y6Q6_Glu610Gly,TNFRSF11A,E610G,p.(Glu610Gly),c.1829A>G,substitution,1,A>G,Uncertain significance (VUS),--,UNKNOWN,NO,--,--,--,Sequencing NGS ,--,Unknown,Undefined-AID ,France/,--,2019-05-13,Pugnet G Rittore C Tharreau M  Boursier G Sarrabay G Touitou I   Personal communication,Exon 10,0.19,0
